
The	The	DT	B-NP	O
commitment	commitment	NN	I-NP	O
stage	stage	NN	I-NP	O
towards	towards	IN	B-PP	O
PMA-induced	PMA-induced	JJ	B-NP	O
macrophage	macrophage	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
increases	increase	NNS	B-NP	O
in	in	IN	B-PP	O
jun	jun	NN	B-NP	B-DNA
B	B	NN	I-NP	I-DNA
and	and	CC	O	O
c-fos	c-fos	NN	B-NP	B-RNA
mRNA	mRNA	NN	B-NP	I-RNA
levels	level	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
AP-1	AP-1	NN	I-NP	I-protein
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
gel	gel	NN	B-NP	O
retardation	retardation	NN	I-NP	O
analysis	analysis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
untreated	untreated	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
drastically	drastically	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
commitment	commitment	NN	I-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
DMSO-induced	DMSO-induced	JJ	B-NP	O
HL-60	HL-60	NN	I-NP	O
differentiation	differentiation	NN	I-NP	O
towards	towards	IN	B-PP	O
granulocytes	granulocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

When	When	WRB	B-ADVP	O
HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
sodium	sodium	NN	B-NP	O
butyrate	butyrate	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
induced	induce	VBD	B-VP	O
monocytic	monocytic	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
remarkable	remarkable	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
1	1	CD	B-NP	O
alpha	alpha	SYM	B-ADJP	O
,	,	,	O	O
25-dihydroxyvitamin	25-dihydroxyvitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
,	,	,	O	O
another	another	DT	B-NP	O
monocytic	monocytic	JJ	I-NP	O
differentiation	differentiation	NN	I-NP	O
agent	agent	NN	I-NP	O
,	,	,	O	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
weak	weak	JJ	I-NP	O
,	,	,	O	O
but	but	CC	O	O
appreciable	appreciable	JJ	B-ADJP	O
,	,	,	O	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
butyrate	butyrate	NN	I-NP	O
or	or	CC	O	O
1	1	CD	B-NP	O
alpha	alpha	NN	I-NP	O
,	,	,	O	O
25-dihydroxyvitamin	25-dihydroxyvitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
to	to	TO	B-PP	O
HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
induced	induce	VBD	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
c-fos	c-fos	NN	B-NP	B-DNA
,	,	,	O	O
c-jun	c-jun	NN	B-NP	B-DNA
,	,	,	O	O
jun	jun	NN	B-NP	B-DNA
B	B	NN	I-NP	I-DNA
and	and	CC	O	O
jun	jun	NN	B-NP	B-DNA
D	D	NN	I-NP	I-DNA
proto-oncogenes	proto-oncogene	NNS	B-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
retinoic	retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
granulocytic	granulocytic	JJ	I-NP	O
differentiation	differentiation	NN	I-NP	O
inducer	inducer	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
enhanced	enhance	VBN	I-NP	O
AP-1	AP-1	NN	I-NP	B-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
weak	weak	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
jun	jun	NN	B-NP	B-RNA
D	D	NN	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
HL-60	HL-60	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
towards	towards	IN	B-PP	O
granulocytes	granulocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
whereas	whereas	IN	O	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
monocytic	monocytic	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
is	be	VBZ	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
differential	differential	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
critical	critical	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
towards	towards	IN	B-PP	O
monocytic	monocytic	JJ	B-NP	O
or	or	CC	I-NP	O
granulocytic	granulocytic	JJ	I-NP	B-cell_type
lineages	lineage	NNS	I-NP	I-cell_type

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
sensitivity	sensitivity	NN	B-NP	O
in	in	IN	B-PP	O
leukemias	leukemia	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
utility	utility	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
determination	determination	NN	I-NP	O
to	to	TO	B-VP	O
predict	predict	VB	I-VP	O
clinical	clinical	JJ	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
leukemias	leukemia	NNS	I-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
studied	study	VBN	I-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
leukemic	leukemic	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
46	46	CD	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
from	from	IN	B-PP	O
18	18	CD	B-NP	O
normal	normal	JJ	I-NP	O
donors	donor	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
3	3	CD	B-NP	O
,	,	,	I-NP	O
875	875	CD	I-NP	O
(	(	(	O	O
Median	Median	NN	B-NP	O
)	)	)	O	O
specific	specific	JJ	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
blasts	blast	NNS	I-NP	B-cell_type
from	from	IN	B-PP	O
17	17	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
ANLL	ANLL	NN	B-NP	O
had	have	VBD	B-VP	O
on	on	IN	B-PP	O
average	average	JJ	B-NP	O
higher	high	JJR	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-NP	O
sites	site	NNS	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
(	(	(	O	O
Median	Median	NN	B-NP	O
=	=	SYM	B-VP	O
7	7	CD	B-NP	O
,	,	,	O	O
250	250	CD	B-NP	O
,	,	,	O	O
range	range	NN	B-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
to	to	TO	I-NP	O
15	15	CD	I-NP	O
,	,	,	I-NP	O
295	295	CD	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
leukemias	leukemia	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
15	15	CD	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
CLL	CLL	NN	B-NP	O
,	,	,	O	O
six	six	CD	B-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
to	to	TO	I-NP	O
5	5	CD	I-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

Their	Their	PRP$	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
had	have	VBD	B-VP	O
lower	low	JJR	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
receptors	receptor	NNS	B-NP	B-protein
(	(	(	O	O
Median	Median	NN	B-NP	O
=	=	SYM	B-VP	O
2	2	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
cases	case	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
newly	newly	RB	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
(	(	(	O	O
Median	Median	NN	B-NP	O
=	=	SYM	B-VP	O
4	4	CD	B-NP	O
,	,	,	O	O
500	500	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Four	Four	CD	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
ALL/AUL	ALL/AUL	NN	B-NP	O
,	,	,	O	O
three	three	CD	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
blast	blast	NN	B-NP	O
crisis	crisis	NN	I-NP	O
as	as	IN	B-PP	O
terminal	terminal	JJ	B-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
CML	CML	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
seven	seven	CD	B-NP	O
had	have	VBD	B-VP	O
leukemic	leukemic	JJ	B-NP	O
Non-Hodgkin	Non-Hodgkin	JJ	I-NP	O
lymphomas	lymphoma	NNS	I-NP	O
(	(	(	O	O
Median	Median	NN	B-NP	O
=	=	SYM	B-VP	O
3	3	CD	B-NP	O
,	,	,	O	O
500	500	CD	B-NP	O
sites/cell	sites/cell	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
24	24	CD	B-NP	O
patients	patient	NNS	I-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
also	also	RB	I-VP	O
studied	study	VBN	I-VP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
leukemic	leukemic	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
marked	marked	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
and	and	CC	O	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
correlate	correlate	VB	I-VP	O
receptor	receptor	NN	B-NP	O
levels	level	NNS	I-NP	O
with	with	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
determination	determination	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
value	value	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	O
malignancies	malignancy	NNS	I-NP	O
but	but	CC	O	O
probably	probably	RB	B-ADVP	O
not	not	RB	O	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
leukemias	leukemia	NNS	I-NP	O
.	.	.	O	O

'Activation-labile	'Activation-labile	JJ	B-NP	O
'	'	''	I-NP	O
glucocorticoid-receptor	glucocorticoid-receptor	NN	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
of	of	IN	B-PP	O
a	a	DT	B-NP	O
steroid-resistant	steroid-resistant	JJ	I-NP	O
variant	variant	NN	I-NP	O
of	of	IN	B-PP	O
CEM-C7	CEM-C7	NN	B-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
lymphoid	lymphoid	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

For	For	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	B-protein
glucocorticoid-receptor	glucocorticoid-receptor	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
to	to	TO	B-VP	O
enter	enter	VB	I-VP	O
and	and	CC	I-VP	O
accumulate	accumulate	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
a	a	DT	B-NP	O
temperature-dependent	temperature-dependent	JJ	I-NP	O
event	event	NN	I-NP	O
,	,	,	O	O
'activation	'activation	NN	B-NP	O
'	'	''	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
.	.	.	O	O

Activation	Activation	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
achieved	achieve	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
increased	increase	VBN	B-NP	O
ionic	ionic	JJ	I-NP	O
strength	strength	NN	I-NP	O
,	,	,	O	O
dilution	dilution	NN	B-NP	O
or	or	CC	O	O
gel	gel	NN	B-NP	O
filtration	filtration	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
manifested	manifest	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
steroid-receptor	steroid-receptor	JJ	B-NP	B-protein
complex	complex	NN	I-NP	I-protein
for	for	IN	B-PP	O
DNA	DNA	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
altered	altered	JJ	I-NP	O
elution	elution	NN	I-NP	O
profile	profile	NN	I-NP	O
from	from	IN	B-PP	O
ion-exchange	ion-exchange	NN	B-NP	B-protein
resins	resin	NNS	I-NP	I-protein
.	.	.	O	O

Munck	Munck	NNP	B-NP	O
and	and	CC	I-NP	O
Foley	Foley	NNP	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
activated	activate	VBN	B-NP	O
complexes	complex	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
thymocytes	thymocyte	NNS	B-NP	B-cell_type
elute	elute	VBP	B-VP	O
from	from	IN	B-PP	O
DEAE-cellulose	DEAE-cellulose	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
manner	manner	NN	I-NP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
complexes	complex	NNS	B-NP	O
activated	activate	VBN	B-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
DEAE-cellulose	DEAE-cellulose	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
of	of	IN	B-PP	O
steroid-receptor	steroid-receptor	JJ	B-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
from	from	IN	B-PP	O
CEM-C7	CEM-C7	NN	B-NP	B-cell_line
,	,	,	O	O
a	a	DT	B-NP	O
cloned	clone	VBN	I-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
leukaemic	leukaemic	JJ	I-NP	I-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cytolytic	cytolytic	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
steroid-resistant	steroid-resistant	JJ	I-NP	B-protein
subclone	subclone	NN	I-NP	I-protein
4R4	4R4	NN	I-NP	I-protein
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
steroid	steroid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
of	of	IN	B-PP	O
clone	clone	NN	B-NP	B-protein
4R4	4R4	NN	I-NP	I-protein
can	can	MD	B-VP	O
not	not	RB	I-VP	O
form	form	VB	I-VP	O
stable	stable	JJ	B-NP	B-protein
activated	activate	VBN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
defines	define	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
receptor	receptor	NN	B-NP	O
action	action	NN	I-NP	O
,	,	,	O	O
activation	activation	NN	B-NP	O
lability	lability	NN	I-NP	O
(	(	(	O	O
r+act1	r+act1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
unlike	unlike	IN	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
r-	r-	NN	I-NP	O
,	,	,	O	O
r+nt-	r+nt-	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
r+nti	r+nti	AFX	B-NP	O
phenotypes	phenotype	NNS	I-NP	O
previously	previously	RB	B-VP	O
described	describe	VBN	I-VP	O
for	for	IN	B-PP	O
mouse	mouse	NN	B-NP	B-cell_line
lymphoid	lymphoid	JJ	I-NP	I-cell_line
variants	variant	NNS	I-NP	I-cell_line
.	.	.	O	O

Granulocytes	Granulocyte	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
endometrium	endometrium	NN	I-NP	O
of	of	IN	B-PP	O
post-partum	post-partum	JJ	B-NP	O
women	woman	NNS	I-NP	O
.	.	.	O	O

Endometrial	Endometrial	JJ	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
women	woman	NNS	B-NP	O
at	at	IN	B-PP	O
various	various	JJ	B-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
gonadal	gonadal	JJ	B-NP	O
activity	activity	NN	I-NP	O
after	after	IN	B-PP	O
parturition	parturition	NN	B-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
and	and	CC	I-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
endometrial	endometrial	JJ	B-NP	B-cell_type
granulocytes	granulocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Although	Although	IN	B-SBAR	O
samples	sample	NNS	B-NP	O
at	at	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
stages	stage	NNS	I-NP	O
contained	contain	VBD	B-VP	O
significant	significant	JJ	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
granulocytes	granulocyte	NNS	I-NP	B-cell_type
(	(	(	O	O
i.e.	i.e.	FW	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
7/high-power	7/high-pow	JJR	B-NP	O
field	field	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
values	value	NNS	I-NP	O
for	for	IN	B-PP	O
late-proliferative	late-proliferative	JJ	B-NP	O
and	and	CC	I-NP	O
adaptation	adaptation	NN	I-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
values	value	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
resting	resting	NN	I-NP	O
(	(	(	O	O
81.8	81.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
early	early	JJ	B-ADVP	O
(	(	(	O	O
82.4	82.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
mid-	mid-	NN	B-NP	O
(	(	(	O	O
87.9	87.9	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
proliferative	proliferative	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
secretory	secretory	JJ	I-ADJP	O
(	(	(	O	O
83.3	83.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
phases	phase	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
correlates	correlate	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
suggestion	suggestion	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
granulocytes	granulocyte	NNS	I-NP	B-cell_type
constitute	constitute	VBP	B-VP	O
a	a	DT	B-NP	O
receptor	receptor	NN	I-NP	O
system	system	NN	I-NP	O
for	for	IN	B-PP	O
oestrogens	oestrogen	NNS	B-NP	O
.	.	.	O	O

Interaction	Interaction	NN	B-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
with	with	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
.	.	.	O	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	O
binding	binding	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
resident	resident	JJ	B-NP	O
and	and	CC	I-NP	O
thioglycollate-elicited	thioglycollate-elicited	JJ	I-NP	B-cell_type
mouse	mouse	NN	I-NP	I-cell_type
peritoneal	peritoneal	JJ	I-NP	I-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
,	,	,	O	O
rabbit	rabbit	NN	B-NP	B-cell_type
alveolar	alveolar	JJ	I-NP	I-cell_type
macrophages	macrophage	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
human	human	JJ	B-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Two	Two	CD	B-NP	O
assays	assay	NNS	I-NP	O
of	of	IN	B-PP	O
binding	binding	NN	B-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
--	--	:	O	O
an	an	DT	B-NP	O
assay	assay	NN	I-NP	O
with	with	IN	B-PP	O
intact	intact	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
suspension	suspension	NN	B-NP	O
or	or	CC	I-NP	O
monolayers	monolayer	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
assay	assay	NN	I-NP	O
of	of	IN	B-PP	O
cytosol	cytosol	NN	B-NP	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
mononuclear	mononuclear	JJ	I-NP	B-cell_type
phagocytes	phagocyte	NNS	I-NP	I-cell_type
contained	contain	VBD	B-VP	O
approximately	approximately	RB	B-ADJP	O
equal	equal	JJ	I-ADJP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
--	--	SYM	B-NP	O
10	10	CD	I-NP	O
X	X	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
)	)	)	O	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
receptor	receptor	NN	I-NP	O
sites	site	NNS	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
dissociation	dissociation	NN	B-NP	O
constants	constant	NNS	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
equal	equal	JJ	I-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
--	--	:	O	O
8	8	CD	B-NP	O
nM	nM	NN	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
saturable	saturable	JJ	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
was	be	VBD	B-VP	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
with	with	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
or	or	CC	I-NP	O
antiglucocorticoid	antiglucocorticoid	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Cortisol	Cortisol	NN	B-NP	O
,	,	,	O	O
corticosterone	corticosterone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	O
competed	compete	VBD	B-VP	O
with	with	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
for	for	IN	B-PP	O
binding	binding	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	B-PP	O
estradiol	estradiol	NN	B-NP	O
,	,	,	O	O
dihydrotestosterone	dihydrotestosterone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
11-epicortisol	11-epicortisol	NN	B-NP	O
competed	compete	VBD	B-VP	O
very	very	RB	B-ADJP	O
little	little	JJ	I-ADJP	O
.	.	.	O	O

Binding	Binding	NN	B-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
to	to	TO	B-PP	O
cytosol	cytosol	NN	B-NP	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
and	and	CC	O	O
temperature-sensitive	temperature-sensitive	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
cytosol	cytosol	NN	B-NP	B-protein
forms	form	NNS	I-NP	I-protein
to	to	TO	B-PP	O
nuclear	nuclear	JJ	B-NP	O
forms	form	NNS	I-NP	O
were	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hormone-receptor	hormone-receptor	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
was	be	VBD	B-VP	O
nuclear	nuclear	JJ	B-ADJP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
corticosteroids	corticosteroid	NNS	B-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
at	at	IN	B-PP	O
physiological	physiological	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
.	.	.	O	O

Nitric	Nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
signaling	signaling	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
G	G	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
reported	report	VBN	I-VP	O
various	various	JJ	B-NP	O
inductive	inductive	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
PBMC	PBMC	NN	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
describe	describe	VBP	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
and	and	CC	I-NP	O
potentially	potentially	RB	I-NP	O
important	important	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
signaling-through	signaling-through	JJ	I-NP	O
direct	direct	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
guanine	guanine	NN	B-NP	B-protein
nucleotide-binding	nucleotide-binding	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
(	(	(	O	O
G	G	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
membranes	membrane	NNS	B-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
fresh	fresh	JJ	B-NP	O
human	human	JJ	I-NP	O
PBMC	PBMC	NN	I-NP	B-cell_type
enhances	enhance	VBZ	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
membranes	membrane	NNS	I-NP	O
to	to	TO	B-VP	O
hydrolyze	hydrolyze	VB	I-VP	O
[	[	(	O	O
gamma-32P	gamma-32P	NN	B-NP	O
]	]	)	O	O
GTP	GTP	NN	B-NP	O
and	and	CC	I-NP	O
bind	bind	NN	I-NP	O
[	[	(	I-NP	O
gamma-35S	gamma-35S	NN	I-NP	O
]	]	)	I-NP	O
GTP	GTP	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
whole	whole	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
yielded	yield	VBD	B-VP	O
membranes	membrane	NNS	B-NP	O
with	with	IN	B-PP	O
enhanced	enhance	VBN	B-NP	O
GTPase	GTPase	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
GTPase	GTPase	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
pure	pure	JJ	B-NP	O
,	,	,	I-NP	O
recombinant	recombinant	JJ	I-NP	B-protein
Gs	Gs	NN	I-NP	I-protein
alpha	alpha	SYM	B-NP	I-protein
,	,	,	O	O
Gi	Gi	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
p21ras	p21ras	NN	B-NP	B-protein
was	be	VBD	B-VP	O
greatly	greatly	RB	I-VP	O
enhanced	enhance	VBN	I-VP	O
by	by	IN	B-PP	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
support	support	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
whole	whole	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
G	G	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
GDP-beta-S	GDP-beta-S	NN	B-NP	B-protein
,	,	,	O	O
blocked	block	VBD	B-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
translocation	translocation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
or	or	CC	I-NP	O
LPS	LPS	NN	I-NP	O
in	in	IN	B-PP	O
permeabilized	permeabilized	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
greatly	greatly	RB	B-VP	O
reduced	reduce	VBD	I-VP	O
the	the	DT	B-NP	O
pertussis	pertussis	NN	I-NP	O
toxin-mediated	toxin-mediated	JJ	I-NP	O
ADP-ribosylation	ADP-ribosylation	NN	I-NP	O
of	of	IN	B-PP	O
45-	45-	CD	B-NP	B-protein
and	and	CC	O	I-protein
41-kDa	41-kDa	JJ	B-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
membranes	membrane	NNS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
G	G	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
diverse	diverse	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
systems	system	NNS	I-NP	O
,	,	,	O	O
activation	activation	NN	B-NP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
endogenous	endogenous	JJ	I-NP	O
and	and	CC	I-NP	O
inducible	inducible	JJ	I-NP	O
oxidant	oxidant	NN	I-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
granulocyte-macrophage	granulocyte-macrophage	JJ	I-NP	B-DNA
colony-stimulating	colony-stimulating	JJ	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
cis-acting	cis-acting	JJ	I-NP	O
element	element	NN	I-NP	O
CLE0	CLE0	NN	I-NP	B-DNA
mediates	mediate	VBZ	B-VP	O
induction	induction	NN	B-NP	O
signals	signal	NNS	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
is	be	VBZ	B-VP	O
recognized	recognize	VBN	I-VP	O
by	by	IN	B-PP	O
factors	factor	NNS	B-NP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
AP1	AP1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NFAT	NFAT	NN	I-NP	B-protein
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
granulocyte-macrophage	granulocyte-macrophage	JJ	I-NP	B-DNA
colony-stimulating	colony-stimulating	JJ	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
(	(	(	O	I-DNA
GM-CSF	GM-CSF	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
(	(	(	O	O
phorbol	phorbol	NN	B-NP	O
myristate	myristate	NN	I-NP	O
acetate	acetate	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
calcium	calcium	NN	B-NP	O
ionophore	ionophore	NN	I-NP	O
(	(	(	O	O
A23187	A23187	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
mimic	mimic	VBP	B-VP	O
antigen	antigen	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
T-cell	T-cell	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
fragment	fragment	NN	I-NP	O
containing	contain	VBG	B-VP	O
bp	bp	NN	B-NP	O
-95	-95	CD	I-NP	O
to	to	TO	B-PP	O
+27	+27	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
GM-CSF	GM-CSF	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
can	can	MD	B-VP	O
confer	confer	VB	I-VP	O
inducibility	inducibility	NN	B-NP	O
to	to	TO	B-PP	O
reporter	reporter	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
Jurkat	Jurkat	NN	I-NP	I-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
use	use	VBP	B-VP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
transcription	transcription	NN	I-NP	O
system	system	NN	I-NP	O
to	to	TO	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
cis-acting	cis-acting	JJ	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
(	(	(	O	O
positions	position	NNS	B-NP	B-DNA
-54	-54	CD	B-NP	I-DNA
to	to	TO	B-PP	I-DNA
-40	-40	CD	B-NP	I-DNA
)	)	)	O	O
,	,	,	O	O
referred	refer	VBN	B-VP	O
to	to	TO	B-PP	O
as	as	IN	B-PP	O
CLE0	CLE0	NN	B-NP	B-DNA
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
signals	signal	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
observed	observe	VBD	B-VP	O
induction	induction	NN	B-NP	O
with	with	IN	B-PP	O
templates	template	NNS	B-NP	O
containing	contain	VBG	B-VP	O
intact	intact	JJ	B-NP	O
CLE0	CLE0	NN	I-NP	B-DNA
but	but	CC	B-PP	O
not	not	RB	B-PP	O
with	with	IN	I-PP	O
templates	template	NNS	B-NP	O
with	with	IN	B-PP	O
deleted	delete	VBN	B-NP	O
or	or	CC	I-NP	O
mutated	mutate	VBN	I-NP	O
CLE0	CLE0	NN	I-NP	B-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
observed	observe	VBD	B-VP	O
that	that	IN	B-SBAR	O
two	two	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
signals	signal	NNS	I-NP	O
were	be	VBD	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
stimulation	stimulation	NN	I-NP	O
through	through	IN	B-PP	O
CLE0	CLE0	NN	B-NP	B-DNA
,	,	,	O	O
since	since	IN	B-SBAR	O
only	only	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
cells	cell	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
both	both	CC	O	O
phorbol	phorbol	NN	B-NP	O
myristate	myristate	NN	I-NP	O
acetate	acetate	NN	I-NP	O
and	and	CC	I-NP	O
A23187	A23187	NN	I-NP	O
supported	support	VBD	B-VP	O
optimal	optimal	JJ	B-NP	O
induction	induction	NN	I-NP	O
.	.	.	O	O

Stimulation	Stimulation	NN	B-NP	O
probably	probably	RB	B-ADVP	O
was	be	VBD	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
CLE0-binding	CLE0-binding	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
because	because	IN	B-SBAR	O
depletion	depletion	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
proteins	protein	NNS	I-NP	O
specifically	specifically	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
binding	bind	VBG	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
possessed	possess	VBD	B-VP	O
biochemical	biochemical	JJ	B-NP	O
and	and	CC	I-NP	O
immunological	immunological	JJ	I-NP	O
features	feature	NNS	I-NP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
AP1	AP1	NN	I-NP	B-protein
.	.	.	O	O

Another	Another	DT	B-NP	O
factor	factor	NN	I-NP	O
resembled	resemble	VBD	B-VP	O
the	the	DT	B-NP	O
T-cell-specific	T-cell-specific	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NFAT	NFAT	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
factors	factor	NNS	I-NP	O
are	be	VBP	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
their	their	PRP$	B-NP	O
involvement	involvement	NN	I-NP	O
in	in	IN	B-PP	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
induction	induction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
CLE0-like	CLE0-like	JJ	B-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
promoters	promoter	NNS	I-NP	B-DNA
of	of	IN	B-PP	O
interleukin-3	interleukin-3	NN	B-NP	B-protein
(	(	(	O	O
IL-3	IL-3	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
IL-4	IL-4	NN	B-NP	B-protein
,	,	,	O	O
IL-5	IL-5	NN	B-NP	B-protein
,	,	,	O	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
NFAT	NFAT	NN	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
factors	factor	NNS	I-NP	O
we	we	PRP	B-NP	O
detected	detect	VBD	B-VP	O
,	,	,	O	O
or	or	CC	O	O
related	relate	VBN	B-NP	O
factors	factor	NNS	I-NP	O
that	that	WDT	B-NP	O
recognize	recognize	VBP	B-VP	O
these	these	DT	B-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
coordinate	coordinate	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
during	during	IN	B-PP	O
T-cell	T-cell	NN	B-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Identification	Identification	NN	B-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
Alu-containing	Alu-containing	JJ	I-NP	O
,	,	,	I-NP	O
T-cell-specific	T-cell-specific	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	B-DNA
intron	intron	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
CD8	CD8	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
CD8	CD8	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
restricted	restrict	VBN	I-VP	O
to	to	TO	B-PP	O
cells	cell	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lymphoid	lymphoid	JJ	I-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
and	and	CC	O	O
developmentally	developmentally	RB	B-VP	O
regulated	regulate	VBN	I-VP	O
during	during	IN	B-PP	O
thymopoiesis	thymopoiesis	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
step	step	NN	I-NP	O
towards	towards	IN	B-PP	O
understanding	understand	VBG	B-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
tissue-specific	tissue-specific	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
surveyed	survey	VBD	B-VP	O
the	the	DT	B-NP	O
surrounding	surround	VBG	I-NP	O
chromatin	chromatin	NN	I-NP	B-DNA
structure	structure	NN	I-NP	O
for	for	IN	B-PP	O
potential	potential	JJ	B-NP	O
cis-acting	cis-acting	JJ	I-NP	B-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
regions	region	NNS	I-NP	I-DNA
by	by	IN	B-PP	O
DNase	DNase	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
hypersensitivity	hypersensitivity	NN	I-NP	O
mapping	mapping	NN	I-NP	O
and	and	CC	O	O
found	find	VBD	B-VP	O
four	four	CD	B-NP	O
hypersensitive	hypersensitive	JJ	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
three	three	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
restricted	restrict	VBN	B-VP	O
.	.	.	O	O

By	By	IN	B-PP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
reporter-based	reporter-based	JJ	I-NP	O
expression	expression	NN	I-NP	O
approach	approach	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
T-cell-specific	T-cell-specific	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
its	its	PRP$	B-NP	O
close	close	JJ	I-NP	O
association	association	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
prominent	prominent	JJ	I-NP	B-DNA
T-cell-restricted	T-cell-restricted	JJ	I-NP	I-DNA
hypersensitive	hypersensitive	JJ	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	B-DNA
intron	intron	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CD8	CD8	NN	I-NP	B-DNA
alpha	alpha	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

Deletion	Deletion	NN	B-NP	O
studies	study	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
minimal	minimal	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
adjacent	adjacent	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	B-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

DNA	DNA	NN	B-NP	O
sequence	sequence	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
minimal	minimal	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
striking	striking	JJ	I-NP	O
cluster	cluster	NN	I-NP	O
of	of	IN	B-PP	O
consensus	consensus	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
Ets-1	Ets-1	NN	B-NP	B-protein
,	,	,	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
,	,	,	O	O
CRE	CRE	NN	B-NP	B-DNA
,	,	,	O	O
GATA-3	GATA-3	NN	B-NP	B-protein
,	,	,	O	O
LyF-1	LyF-1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
bHLH	bHLH	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
verified	verify	VBN	I-VP	O
by	by	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
end	end	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
enhancer	enhancer	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
Alu	Alu	NN	I-NP	B-DNA
repeat	repeat	NN	I-NP	I-DNA
which	which	WDT	B-NP	O
contained	contain	VBD	B-VP	O
the	the	DT	B-NP	O
GATA-3	GATA-3	NN	I-NP	B-protein
,	,	,	O	O
bHLH	bHLH	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
LyF-1	LyF-1	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

Site-directed	Site-directed	JJ	B-NP	O
mutation	mutation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ets-1	Ets-1	NN	I-NP	B-protein
and	and	CC	I-NP	O
GATA-3	GATA-3	NN	I-NP	O
sites	site	NNS	I-NP	O
dramatically	dramatically	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
enhancer	enhancer	NN	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
functional	functional	JJ	I-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
binding	bind	VBG	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
only	only	RB	B-ADVP	O
became	become	VBD	B-VP	O
apparent	apparent	JJ	B-ADJP	O
when	when	WRB	B-ADVP	O
combinations	combination	NNS	B-NP	O
of	of	IN	B-PP	O
mutations	mutation	NNS	B-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
.	.	.	O	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
CD8	CD8	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	B-protein
nuclear	nuclear	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	B-DNA
intron	intron	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
.	.	.	O	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CD8	CD8	NN	I-NP	B-DNA
alpha	alpha	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
recently	recently	RB	I-NP	O
identified	identify	VBN	I-NP	O
T-cell-specific	T-cell-specific	JJ	I-NP	B-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
regulates	regulate	VBZ	B-VP	O
several	several	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Molecular	Molecular	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
IL-3	IL-3	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
:	:	:	O	O
inducible	inducible	JJ	B-NP	O
T	T	NN	I-NP	O
cell-restricted	cell-restricted	JJ	I-NP	O
expression	expression	NN	I-NP	O
requires	require	VBZ	B-VP	O
intact	intact	JJ	B-NP	O
AP-1	AP-1	NN	I-NP	B-protein
and	and	CC	I-NP	O
Elf-1	Elf-1	NN	I-NP	B-protein
nuclear	nuclear	JJ	I-NP	O
protein	protein	NN	I-NP	O
binding	binding	NN	I-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O

Interleukin	Interleukin	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
(	(	(	O	O
IL-3	IL-3	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
hematopoietic	hematopoietic	JJ	I-NP	B-protein
stem-cell	stem-cell	NN	I-NP	I-protein
growth	growth	NN	I-NP	I-protein
and	and	CC	O	I-protein
differentiation	differentiation	NN	B-NP	I-protein
factor	factor	NN	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
solely	solely	RB	B-ADVP	O
in	in	IN	B-PP	O
activated	activate	VBN	B-NP	O
T	T	NN	I-NP	O
and	and	CC	I-NP	O
NK	NK	NN	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
elements	element	NNS	B-NP	O
5	5	CD	B-NP	O
'	'	SYM	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
IL-3	IL-3	NN	I-NP	B-DNA
coding	coding	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
that	that	WDT	B-NP	O
regulate	regulate	VBP	B-VP	O
its	its	PRP$	B-NP	O
transcription	transcription	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
that	that	WDT	B-NP	O
confer	confer	VBP	B-VP	O
T	T	NN	B-NP	O
cell-specific	cell-specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
remain	remain	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
clearly	clearly	RB	I-VP	O
defined	define	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
now	now	RB	I-VP	O
identified	identify	VBN	I-VP	O
DNA	DNA	NN	B-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
T	T	NN	B-NP	B-DNA
cell-restricted	cell-restricted	JJ	I-NP	I-DNA
IL-3	IL-3	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfections	transfection	NNS	I-NP	O
performed	perform	VBN	B-VP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	B-DNA
IL-3-chloramphenicol	IL-3-chloramphenicol	NN	I-NP	I-DNA
acetyltransferase	acetyltransferase	NN	I-NP	I-DNA
(	(	(	O	I-DNA
CAT	CAT	NN	B-NP	I-DNA
)	)	)	O	I-DNA
reporter	reporter	NN	B-NP	I-DNA
plasmids	plasmid	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
non-T	non-T	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	B-DNA
containing	contain	VBG	B-VP	O
319	319	CD	B-NP	O
bp	bp	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	B-DNA
'	'	SYM	I-NP	I-DNA
flanking	flanking	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
was	be	VBD	B-VP	O
active	active	JJ	B-ADJP	O
exclusively	exclusively	RB	B-ADVP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Deletion	Deletion	NN	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
specificity	specificity	NN	I-NP	O
was	be	VBD	B-VP	O
conferred	confer	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
49-bp	49-bp	JJ	I-NP	B-DNA
fragment	fragment	NN	I-NP	I-DNA
(	(	(	O	O
bp	bp	NN	B-NP	O
-319	-319	CD	I-NP	O
to	to	TO	I-NP	O
-270	-270	CD	I-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
included	include	VBD	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
binding	bind	VBG	I-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
AP-1	AP-1	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	O
factors	factor	NNS	I-NP	O
6	6	CD	B-NP	O
bp	bp	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
binding	bind	VBG	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
for	for	IN	B-PP	O
Elf-1	Elf-1	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ets	Ets	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

DNaseI	DNaseI	NN	B-NP	B-protein
footprint	footprint	NN	I-NP	O
and	and	CC	O	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
performed	perform	VBN	B-VP	O
with	with	IN	B-PP	O
MLA-144	MLA-144	NN	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
49-bp	49-bp	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
region	region	NN	I-NP	I-protein
that	that	WDT	B-NP	O
includes	include	VBZ	B-VP	O
consensus	consensus	NN	B-NP	B-DNA
AP-1	AP-1	NN	I-NP	I-DNA
and	and	CC	O	I-DNA
Elf-1	Elf-1	NN	B-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
extracts	extract	NNS	B-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
purified	purify	VBN	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
contained	contain	VBD	B-VP	O
proteins	protein	NNS	B-NP	O
that	that	WDT	B-NP	O
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
synthetic	synthetic	JJ	B-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
Elf-1	Elf-1	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
vitro-transcribed	vitro-transcribed	JJ	B-NP	O
and	and	CC	I-NP	O
-translated	-translated	JJ	I-NP	O
Elf-1	Elf-1	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
bound	bind	VBD	B-VP	O
specifically	specifically	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Elf-1	Elf-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
Elf-1	Elf-1	NN	B-NP	B-protein
antisera	antiserum	NNS	I-NP	O
competed	compete	VBD	B-VP	O
and	and	CC	O	O
super	super	JJ	B-NP	O
shifted	shift	VBN	I-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
MLA-144	MLA-144	NN	B-NP	O
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
anti-Jun	anti-Jun	JJ	B-NP	B-protein
family	family	NN	I-NP	I-protein
antiserum	antiserum	NN	I-NP	O
in	in	IN	B-PP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
reactions	reaction	NNS	I-NP	O
completely	completely	RB	B-ADVP	O
blocked	block	VBD	B-VP	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AP-1-related	AP-1-related	JJ	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
.	.	.	O	O

Transient	Transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
studies	study	NNS	I-NP	O
in	in	IN	B-PP	O
MLA-144	MLA-144	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
constructs	construct	NNS	B-NP	O
containing	contain	VBG	B-VP	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
almost	almost	RB	B-ADVP	O
completely	completely	RB	I-ADVP	O
abolished	abolish	VBD	B-VP	O
CAT	CAT	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
while	while	IN	B-SBAR	O
mutation	mutation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Elf-1	Elf-1	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
or	or	CC	O	O
the	the	DT	B-NP	O
NF-IL-3	NF-IL-3	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
described	describe	VBN	I-NP	O
nuclear	nuclear	JJ	I-NP	B-DNA
protein	protein	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
(	(	(	O	O
bp.	bp.	NN	B-NP	B-DNA
-155	-155	CD	I-NP	I-DNA
to	to	TO	I-NP	I-DNA
-148	-148	CD	I-NP	I-DNA
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IL-3	IL-3	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
,	,	,	O	O
reduced	reduce	VBD	B-VP	O
CAT	CAT	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
<	<	SYM	B-NP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
given	give	VBN	B-VP	O
by	by	IN	B-PP	O
wild-type	wild-type	JJ	B-NP	B-DNA
constructs	construct	NNS	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
IL-3	IL-3	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
requires	require	VBZ	B-VP	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
Elf-1	Elf-1	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
unlike	unlike	IN	B-PP	O
other	other	JJ	B-NP	O
previously	previously	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
cytokine	cytokine	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
IL-2	IL-2	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
AP-1	AP-1	NN	I-NP	B-protein
and	and	CC	I-NP	O
Elf-1	Elf-1	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
can	can	MD	B-VP	O
bind	bind	VB	I-VP	O
independently	independently	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IL-3	IL-3	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-PP	O
400	400	CD	B-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O

Combination	Combination	NN	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
and	and	CC	I-NP	O
IL-4	IL-4	NN	I-NP	B-protein
reduces	reduce	VBZ	B-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
receptor-binding	receptor-binding	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
and	and	CC	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
contributing	contribute	VBG	B-VP	O
to	to	TO	B-PP	O
persistent	persistent	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
in	in	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
illnesses	illness	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
steroid	steroid	NN	B-NP	O
resistant	resistant	JJ	B-ADJP	O
(	(	(	O	O
SR	SR	NN	B-NP	O
)	)	)	I-NP	O
asthma	asthma	NN	I-NP	O
are	be	VBP	B-VP	O
poorly	poorly	RB	I-VP	O
defined	define	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
certain	certain	JJ	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
,	,	,	O	O
specifically	specifically	RB	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
and	and	CC	I-NP	O
IL-4	IL-4	NN	I-NP	B-protein
,	,	,	O	O
could	could	MD	B-VP	O
affect	affect	VB	I-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
[	[	(	I-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
radioligand-binding	radioligand-binding	JJ	I-NP	O
assay	assay	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
dissociation	dissociation	NN	B-NP	O
constant	constant	NN	I-NP	O
(	(	(	O	O
Kd	Kd	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
PBMC	PBMC	NN	B-NP	B-cell_type
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
donors	donor	NNS	I-NP	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
SR	SR	NN	B-NP	O
asthma	asthma	NN	I-NP	O
,	,	,	O	O
cultured	culture	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
and	and	CC	I-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
.	.	.	O	O

PBMC	PBMC	NN	B-NP	B-cell_type
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
donors	donor	NNS	I-NP	O
incubated	incubate	VBN	B-VP	O
for	for	IN	B-PP	O
48	48	CD	B-NP	O
h	h	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
combination	combination	NN	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
+	+	SYM	O	O
IL-4	IL-4	NN	B-NP	B-protein
had	have	VBD	B-VP	O
nuclear	nuclear	JJ	B-NP	O
GR	GR	NN	I-NP	B-protein
with	with	IN	B-PP	O
significantly	significantly	RB	B-NP	O
reduced	reduce	VBN	I-NP	O
binding	binding	NN	I-NP	O
affinity	affinity	NN	I-NP	O
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
Kd	Kd	NN	I-NP	O
=	=	SYM	B-VP	O
36.1	36.1	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
1.63	1.63	CD	I-NP	O
nM	nM	NN	I-NP	O
,	,	,	O	O
mean	mean	NN	B-NP	O
+/-	+/-	CC	I-NP	O
SEM	SEM	NN	I-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.0001	0.0001	CD	B-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
PBMC	PBMC	NN	B-NP	B-cell_type
incubated	incubate	VBN	B-VP	O
with	with	IN	B-PP	O
medium	medium	NN	B-NP	O
alone	alone	RB	B-ADVP	O
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
Kd	Kd	NN	I-NP	O
=	=	SYM	B-VP	O
6.74	6.74	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.46	0.46	CD	I-NP	O
nM	nM	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
cytosolic	cytosolic	JJ	I-NP	O
GR	GR	NN	I-NP	O
Kd	Kd	NN	I-NP	O
remained	remain	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
PBMC	PBMC	NN	B-NP	B-cell_type
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
with	with	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
or	or	CC	O	O
IL-4	IL-4	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
GR-binding	GR-binding	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
non-T	non-T	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
individually	individually	RB	I-VP	O
stimulated	stimulate	VBN	I-VP	O
with	with	IN	B-PP	O
combination	combination	NN	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
+	+	CC	I-NP	O
IL-4	IL-4	NN	I-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
GR-binding	GR-binding	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
population	population	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.0001	0.0001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
+	+	SYM	B-VP	O
IL-4-induced	IL-4-induced	JJ	B-NP	O
alteration	alteration	NN	I-NP	O
in	in	IN	B-PP	O
PBMC	PBMC	NN	B-NP	B-cell_type
GR	GR	NN	I-NP	O
Kd	Kd	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
number	number	NN	I-NP	O
(	(	(	O	O
8348	8348	CD	B-NP	O
+/-	+/-	CC	I-NP	O
964	964	CD	I-NP	O
vs	vs	CC	I-NP	O
1710	1710	CD	I-NP	O
+/-	+/-	CC	I-NP	O
228	228	CD	I-NP	O
sites/cell	sites/cell	NNS	I-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.0003	0.0003	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

More	More	RBR	B-ADVP	O
importantly	importantly	RB	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
alteration	alteration	NN	I-NP	O
in	in	IN	B-PP	O
PBMC	PBMC	NN	B-NP	B-cell_type
GR-binding	GR-binding	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
with	with	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
+	+	CC	I-NP	O
IL-4	IL-4	NN	I-NP	B-protein
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
response	response	NN	I-NP	O
to	to	TO	B-PP	O
methylprednisolone	methylprednisolone	NN	B-NP	O
MPN	MPN	NN	I-NP	O
,	,	,	O	O
i.e.	i.e.	FW	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
MPN	MPN	NN	B-NP	B-protein
on	on	IN	B-PP	O
PMA/ionomycin-induced	PMA/ionomycin-induced	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
+	+	CC	I-NP	O
IL-4	IL-4	NN	I-NP	B-protein
on	on	IN	B-PP	O
PBMC	PBMC	NN	B-NP	B-cell_type
GR	GR	NN	I-NP	O
affinity	affinity	NN	I-NP	O
and	and	CC	O	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
MPN	MPN	NN	B-NP	B-protein
were	be	VBD	B-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
co-incubation	co-incubation	NN	B-NP	O
with	with	IN	B-PP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
.	.	.	O	O

Freshly	Freshly	RB	B-NP	O
isolated	isolate	VBN	I-NP	O
PBMC	PBMC	NN	I-NP	B-cell_type
from	from	IN	B-PP	O
four	four	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
SR	SR	NN	B-NP	O
asthma	asthma	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
reduced	reduce	VBN	I-NP	O
GR-binding	GR-binding	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
(	(	(	O	O
Kd	Kd	NN	B-NP	O
=	=	SYM	B-VP	O
40.0	40.0	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
2.68	2.68	CD	I-NP	O
nM	nM	NN	I-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.0001	0.0001	CD	B-NP	O
)	)	)	O	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
seven	seven	CD	B-NP	O
normal	normal	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
(	(	(	O	O
7.15	7.15	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.41	0.41	CD	I-NP	O
nM	nM	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
altered	altered	JJ	I-NP	O
PBMC	PBMC	NN	I-NP	B-cell_type
GR	GR	NN	I-NP	O
binding	binding	NN	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
SR	SR	NN	B-NP	O
asthma	asthma	NN	I-NP	O
reversed	reverse	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-ADJP	O
when	when	WRB	B-ADVP	O
incubated	incubate	VBN	B-VP	O
with	with	IN	B-PP	O
medium	medium	NN	B-NP	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
sustained	sustain	VBN	I-VP	O
with	with	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
+	+	SYM	B-NP	O
IL-4	IL-4	NN	I-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
observations	observation	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
with	with	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
certain	certain	JJ	I-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
impaired	impaired	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-4	IL-4	NN	I-NP	B-protein
were	be	VBD	B-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
.	.	.	O	O

Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
CD4	CD4	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
:	:	:	O	O
transcription	transcription	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
CD4	CD4	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
core	core	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
tissue-specific	tissue-specific	JJ	B-ADJP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
Ets	Ets	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
transcription	transcription	NN	I-NP	I-DNA
control	control	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
CD4	CD4	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
located	locate	VBD	B-VP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-DNA
initiation	initiation	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
and	and	CC	O	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
CD4	CD4	NN	I-NP	B-DNA
core	core	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
(	(	(	O	O
positions	position	NNS	B-NP	O
-40	-40	CD	B-NP	O
to	to	TO	B-PP	O
+16	+16	CD	B-NP	O
)	)	)	O	O
lacks	lack	VBZ	B-VP	O
a	a	DT	B-NP	O
classical	classical	JJ	I-NP	O
``	``	``	I-NP	O
TATA	TATA	NN	I-NP	B-DNA
''	''	''	O	I-DNA
or	or	CC	O	O
initiator	initiator	NN	B-NP	O
positioning	position	VBG	B-VP	O
consensus	consensus	NN	B-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
but	but	CC	O	O
directs	direct	VBZ	B-VP	O
precise	precise	JJ	B-NP	O
and	and	CC	I-NP	O
efficient	efficient	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
when	when	WRB	B-ADVP	O
coupled	couple	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ubiquitously	ubiquitously	RB	I-NP	B-DNA
active	active	JJ	I-NP	I-DNA
simian	simian	JJ	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
40	40	CD	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CD4	CD4	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
CD4	CD4	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
CD4	CD4	NN	I-NP	B-DNA
core	core	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
also	also	RB	B-ADVP	O
displayed	display	VBD	B-VP	O
a	a	DT	B-NP	O
tissue-specific	tissue-specific	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Within	Within	IN	B-PP	O
this	this	DT	B-NP	O
fragment	fragment	NN	I-NP	O
,	,	,	O	O
three	three	CD	B-NP	O
nucleic	nucleic	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
are	be	VBP	B-VP	O
completely	completely	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	B-DNA
CD4	CD4	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
perfect	perfect	JJ	I-NP	B-DNA
ETS	ETS	NN	I-NP	I-DNA
consensus	consensus	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
.	.	.	O	O

Another	Another	DT	B-NP	O
ETS	ETS	NN	I-NP	B-DNA
consensus	consensus	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
located	located	JJ	B-NP	O
1060	1060	CD	I-NP	O
nt	nt	NN	I-NP	O
upstream	upstream	RB	B-ADVP	O
.	.	.	O	O

Electrophoretic-mobility-shift	Electrophoretic-mobility-shift	JJ	B-NP	O
assays	assay	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
core	core	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
ETS	ETS	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
binds	bind	VBZ	B-VP	O
an	an	DT	B-NP	O
Ets-related	Ets-related	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
specifically	specifically	RB	B-VP	O
expressed	express	VBN	I-VP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
CD4+	CD4+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
CD4-	CD4-	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
Ets-1	Ets-1	NN	B-NP	B-protein
or	or	CC	I-NP	O
Ets-2	Ets-2	NN	I-NP	B-protein
efficiently	efficiently	RB	B-ADVP	O
and	and	CC	I-ADVP	O
specifically	specifically	RB	I-ADVP	O
activated	activate	VBN	B-NP	O
transcription	transcription	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
CD4	CD4	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	I-NP	O
core	core	NN	I-NP	O
promoter	promoter	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
Ets	Ets	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
controlling	control	VBG	B-VP	O
CD4	CD4	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
both	both	CC	O	O
a	a	DT	B-NP	O
classical	classical	JJ	I-NP	B-DNA
remote	remote	JJ	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
and	and	CC	O	O
an	an	DT	B-NP	O
unusual	unusual	JJ	I-NP	B-DNA
proximal	proximal	JJ	I-NP	I-DNA
activator	activator	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
and	and	CC	O	O
inactivation	inactivation	NN	B-NP	O
in	in	IN	B-PP	O
c	c	NN	B-NP	O
ultured	ulture	VBN	B-VP	O
human	human	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Although	Although	IN	B-SBAR	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
cytolytic	cytolytic	JJ	B-ADJP	O
for	for	IN	B-PP	O
and	and	CC	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
inhibit	inhibit	VB	I-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IM-9	IM-9	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
of	of	IN	B-PP	O
cultured	culture	VBN	B-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_line
,	,	,	O	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
steroid-binding	steroid-binding	JJ	I-NP	O
capacity	capacity	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
IM-9	IM-9	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
unoccupied	unoccupied	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
inactivated	inactivate	VBN	I-VP	O
and	and	CC	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
intact	intact	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

when	when	WRB	B-ADVP	O
IM-9	IM-9	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
are	be	VBP	B-VP	O
incubated	incubate	VBN	I-VP	O
in	in	IN	B-PP	O
glucose-free	glucose-free	JJ	B-NP	O
medium	medium	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
nitrogen	nitrogen	NN	I-NP	O
atmosphere	atmosphere	NN	I-NP	O
,	,	,	O	O
both	both	DT	O	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
triamcinolone	triamcinolone	NN	B-NP	O
acetonide	acetonide	NN	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
ATP	ATP	NN	I-NP	O
levels	level	NNS	I-NP	O
decline	decline	VBP	B-VP	O
and	and	CC	O	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
glucose	glucose	NN	B-NP	O
and	and	CC	I-NP	O
oxygen	oxygen	NN	I-NP	O
are	be	VBP	B-VP	O
reintroduced	reintroduce	VBN	I-VP	O
,	,	,	O	O
ATP	ATP	NN	B-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
receptor	receptor	NN	B-NP	O
activity	activity	NN	I-NP	O
return	return	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
specific	specific	JJ	I-NP	O
glucocorticoid-binding	glucocorticoid-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
cytosol	cytosol	NN	B-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
cells	cell	NNS	B-NP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
various	various	JJ	B-NP	O
degrees	degree	NNS	I-NP	O
of	of	IN	B-PP	O
energy	energy	NN	B-NP	O
limitation	limitation	NN	I-NP	O
is	be	VBZ	B-VP	O
directly	directly	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
ATP	ATP	NN	I-NP	O
content	content	NN	I-NP	O
.	.	.	O	O

Receptor	Receptor	NN	B-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
intact	intact	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
rapid	rapid	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
independent	independent	JJ	I-ADJP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
.	.	.	O	O

Cytosol	Cytosol	NN	B-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
inactivated	inactivate	VBN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
ATP	ATP	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
inactivation	inactivation	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
occurs	occur	VBZ	B-VP	O
when	when	WRB	B-ADVP	O
cytosol	cytosol	NN	B-NP	O
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_line
IM-9	IM-9	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
is	be	VBZ	B-VP	O
incubated	incubate	VBN	I-VP	O
at	at	IN	B-PP	O
25	25	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
is	be	VBZ	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
molybdate	molybdate	NN	B-NP	O
,	,	,	O	O
vanadate	vanadate	NN	B-NP	O
,	,	,	O	O
fluoride	fluoride	NN	B-NP	O
,	,	,	O	O
ATP	ATP	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
several	several	JJ	B-NP	O
other	other	JJ	I-NP	O
nucleotides	nucleotide	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
experiments	experiment	NNS	I-NP	O
with	with	IN	B-PP	O
intact	intact	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_type
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
assays	assay	NNS	B-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
glucocorticoid-binding	glucocorticoid-binding	JJ	I-NP	O
capacity	capacity	NN	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
necessarily	necessarily	RB	I-VP	O
reflect	reflect	VB	I-VP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

Glucocorticoids	Glucocorticoid	NNS	B-NP	O
and	and	CC	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
.	.	.	O	O

II	II	CD	B-NP	O
.	.	.	O	O

Cell	Cell	NN	B-NP	O
cycle-dependent	cycle-dependent	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
content	content	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
variations	variation	NNS	B-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
separated	separate	VBN	I-VP	O
mitogen-stimulated	mitogen-stimulated	JJ	B-NP	O
human	human	JJ	I-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
rat	rat	NN	B-NP	B-cell_type
lymph	lymph	NN	I-NP	I-cell_type
node	node	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
unit	unit	NN	B-NP	O
gravity	gravity	NN	I-NP	O
sedimentation	sedimentation	NN	I-NP	O
and	and	CC	O	O
measured	measure	VBN	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
resultant	resultant	JJ	I-NP	O
fractions	fraction	NNS	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
morphologic	morphologic	JJ	B-NP	O
criteria	criterion	NNS	I-NP	O
and	and	CC	O	O
thymidine	thymidine	NN	B-NP	O
incorporation	incorporation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
fractions	fraction	NNS	I-NP	O
were	be	VBD	B-VP	O
separated	separate	VBN	I-VP	O
into	into	IN	B-PP	O
populations	population	NNS	B-NP	O
of	of	IN	B-PP	O
G0	G0	NN	B-NP	O
and	and	CC	I-NP	O
G1	G1	NN	I-NP	O
phase	phase	NN	I-NP	O
and	and	CC	O	O
S	S	NN	B-NP	O
and	and	CC	O	O
post-S	post-S	JJ	B-NP	O
phase	phase	NN	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
2-	2-	CD	I-NP	O
to	to	TO	B-PP	O
3-fold	3-fold	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
sites	site	NNS	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
S	S	NN	I-NP	O
and	and	CC	I-NP	O
post-S	post-S	JJ	I-NP	O
phase	phase	NN	I-NP	O
over	over	IN	B-PP	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
G0	G0	NN	B-NP	O
and	and	CC	I-NP	O
G1	G1	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
with	with	IN	B-PP	O
both	both	CC	B-NP	O
nonstimulated	nonstimulated	JJ	I-NP	O
rat	rat	NN	I-NP	O
lymph	lymph	NN	I-NP	O
node	node	NN	I-NP	O
cell	cell	NN	I-NP	O
suspensions	suspension	NNS	I-NP	O
and	and	CC	O	O
concanavalin	concanavalin	NN	B-NP	O
A-stimulated	A-stimulated	JJ	I-NP	O
human	human	JJ	I-NP	O
peripheral	peripheral	JJ	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
observations	observation	NNS	I-NP	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
studies	study	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
near	near	IN	B-PP	O
the	the	DT	B-NP	O
S	S	NN	I-NP	O
phase	phase	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
general	general	JJ	I-NP	O
phenomenon	phenomenon	NN	I-NP	O
in	in	IN	B-PP	O
proliferating	proliferate	VBG	B-VP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
during	during	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
may	may	MD	B-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
mitogen-stimulated	mitogen-stimulated	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
leukocyte	leukocyte	NN	I-NP	O
migration	migration	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
certain	certain	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer-related	cancer-related	JJ	I-NP	O
antigens	antigen	NNS	I-NP	O
(	(	(	O	O
MCF-7	MCF-7	NN	B-NP	B-protein
and	and	CC	O	O
MuMTV	MuMTV	NN	B-NP	O
)	)	)	O	O
:	:	:	O	O
their	their	PRP$	B-NP	O
potential	potential	NN	I-NP	O
as	as	IN	B-PP	O
discriminants	discriminant	NNS	B-NP	O
.	.	.	O	O

Certain	Certain	JJ	B-NP	O
oncogenic	oncogenic	JJ	I-NP	O
viruses	virus	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
MuMTV	MuMTV	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Mason-Pfizer	Mason-Pfizer	NNP	I-NP	O
monkey	monkey	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
MPMV	MPMV	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
used	use	VBN	I-VP	O
the	the	DT	B-NP	O
leukocyte	leukocyte	NN	I-NP	O
migration	migration	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
(	(	(	O	O
LMI	LMI	NN	B-NP	O
)	)	)	O	O
response	response	NN	B-NP	O
to	to	TO	B-VP	O
assay	assay	VB	I-VP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
several	several	JJ	B-NP	O
potential	potential	JJ	I-NP	O
breast	breast	NN	I-NP	O
cancer-related	cancer-related	JJ	I-NP	O
antigens	antigen	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
MuMTV	MuMTV	NN	B-NP	B-protein
,	,	,	O	O
MPMV	MPMV	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
breast	breast	NN	I-NP	B-cell_line
cancer	cancer	NN	I-NP	I-cell_line
cultured	culture	VBN	B-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
MCF-7	MCF-7	NN	B-NP	B-protein
,	,	,	O	O
in	in	IN	B-PP	O
96	96	CD	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
32	32	CD	B-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
benign	benign	JJ	B-NP	O
breast	breast	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
67	67	CD	B-NP	O
normal	normal	JJ	I-NP	O
women	woman	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lowest	low	JJS	I-NP	O
tenth	tenth	NN	I-NP	O
percentile	percentile	NN	I-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
(	(	(	O	O
LMI	LMI	NN	B-NP	O
)	)	)	O	O
responses	response	NNS	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
cutoff	cutoff	NN	I-NP	O
point	point	NN	I-NP	O
to	to	TO	B-VP	O
designate	designate	VB	I-VP	O
responders	responder	NNS	B-NP	O
.	.	.	O	O

Breast	Breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
patients	patient	NNS	I-NP	O
showed	show	VBD	B-VP	O
significant	significant	JJ	B-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
MuMTV	MuMTV	NN	B-NP	B-protein
(	(	(	O	O
49	49	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
MCF-7	MCF-7	NN	B-NP	B-protein
(	(	(	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
to	to	TO	B-PP	O
MPMV	MPMV	NN	B-NP	O
(	(	(	O	O
29	29	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
paired-antigen	paired-antigen	NN	I-NP	O
study	study	NN	I-NP	O
using	use	VBG	B-VP	O
MuMTV	MuMTV	NN	B-NP	B-protein
and	and	CC	I-NP	O
MCF-7	MCF-7	NN	I-NP	B-protein
,	,	,	O	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
patients	patient	NNS	I-NP	O
responded	respond	VBD	B-VP	O
,	,	,	O	O
versus	versus	IN	B-ADVP	O
18	18	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
women	woman	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.0050	0.0050	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
potential	potential	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
assay	assay	NN	I-NP	O
to	to	TO	B-VP	O
distinguish	distinguish	VB	I-VP	O
``	``	``	O	O
normal	normal	JJ	B-ADJP	O
''	''	''	O	O
from	from	IN	B-PP	O
``	``	``	O	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
''	''	''	O	O
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
using	use	VBG	I-VP	O
a	a	DT	B-NP	O
migration	migration	NN	I-NP	O
index	index	NN	I-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
discriminant	discriminant	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
assay	assay	NN	I-NP	O
to	to	TO	B-VP	O
discriminate	discriminate	VB	I-VP	O
``	``	``	O	O
normal	normal	JJ	B-ADJP	O
''	''	''	O	O
from	from	IN	B-PP	O
``	``	``	O	O
cancer	cancer	NN	B-NP	O
''	''	''	O	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
detecting	detect	VBG	B-VP	O
``	``	``	B-NP	O
cancer	cancer	NN	I-NP	O
''	''	''	O	O
of	of	IN	B-PP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
overall	overall	JJ	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
MuMTV	MuMTV	NN	B-NP	B-protein
and	and	CC	I-NP	O
MCF-7	MCF-7	NN	I-NP	B-protein
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
with	with	IN	B-PP	O
reference	reference	NN	B-NP	O
to	to	TO	B-PP	O
certain	certain	JJ	B-NP	O
prognostic	prognostic	JJ	I-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
relation	relation	NN	I-NP	O
to	to	TO	B-PP	O
age	age	NN	B-NP	O
,	,	,	O	O
menstrual	menstrual	JJ	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
estrogen	estrogen	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
status	status	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
stage	stage	NN	B-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
above	above	JJ	I-NP	O
reactions	reaction	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
patients	patient	NNS	I-NP	O
exhibit	exhibit	VBP	B-VP	O
presensitization	presensitization	NN	B-NP	O
to	to	TO	B-PP	O
antigenfs	antigenf	NNS	B-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
MuMTV	MuMTV	NN	B-NP	O
and	and	CC	I-NP	O
MCF-7	MCF-7	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
cross-reactive	cross-reactive	JJ	B-ADJP	O
with	with	IN	B-PP	O
antigens	antigen	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
responses	response	NNS	I-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
major	major	JJ	B-NP	O
prognostic	prognostic	JJ	I-NP	O
variables	variable	NNS	I-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
refinement	refinement	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
assay	assay	NN	I-NP	O
may	may	MD	B-VP	O
yield	yield	VB	I-VP	O
one	one	CD	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
more	more	RBR	B-ADVP	O
highly	highly	RB	I-ADVP	O
discriminating	discriminate	VBG	B-VP	O
for	for	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
lymphatic	lymphatic	JJ	I-NP	O
leukaemia	leukaemia	NN	I-NP	O
:	:	:	O	O
cellular	cellular	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
in	in	FW	B-ADJP	O
vitro	vitro	FW	I-ADJP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
and	and	CC	O	O
steroid	steroid	NN	B-NP	O
induced	induce	VBD	B-VP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
nucleic	nucleic	JJ	B-NP	B-protein
acid	acid	NN	I-NP	I-protein
precursors	precursor	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
examined	examine	VBN	I-VP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
27	27	CD	B-NP	O
patients	patient	NNS	I-NP	O
at	at	IN	B-PP	O
different	different	JJ	B-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
lymphatic	lymphatic	JJ	I-NP	O
leukaemia	leukaemia	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
correlation	correlation	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.02	0.02	CD	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
stage	stage	NN	B-NP	O
O	O	NN	I-NP	O
and	and	CC	O	O
stage	stage	NN	B-NP	O
III/IV	III/IV	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
on	on	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
uridine	uridine	NN	I-NP	O
incorporation	incorporation	NN	I-NP	O
.	.	.	O	O

Pyrrolidine	Pyrrolidine	NN	B-NP	O
dithiocarbamate	dithiocarbamate	NN	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
mobilization	mobilization	NN	I-NP	O
and	and	CC	O	O
TNF	TNF	NN	B-NP	B-protein
production	production	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
TNF	TNF	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
four	four	CD	B-NP	O
potential	potential	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor-kappa	factor-kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
(	(	(	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
)	)	)	O	O
-binding	-binding	JJ	B-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
strongest	strong	JJS	I-NP	O
binding	binding	NN	I-NP	O
seen	see	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
-605	-605	CD	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
unstimulated	unstimulated	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
monocytic	monocytic	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
Mono	Mono	NN	B-NP	B-cell_line
Mac	Mac	NN	I-NP	I-cell_line
6	6	CD	I-NP	I-cell_line
,	,	,	O	O
contain	contain	VBP	B-VP	O
one	one	CD	B-NP	O
specific	specific	JJ	I-NP	O
binding	bind	VBG	I-NP	O
protein	protein	NN	I-NP	O
(	(	(	O	O
complex	complex	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	B-protein
p50	p50	NN	I-NP	I-protein
homodimer	homodimer	NN	I-NP	I-protein
.	.	.	O	O

Stimulation	Stimulation	NN	B-NP	O
of	of	IN	B-PP	O
Mono	Mono	NN	B-NP	B-cell_line
Mac	Mac	NN	I-NP	I-cell_line
6	6	CD	B-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
LPS	LPS	NN	B-NP	O
will	will	MD	B-VP	O
increase	increase	VB	I-VP	O
complex	complex	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
and	and	CC	O	O
will	will	MD	B-VP	O
strongly	strongly	RB	I-VP	O
induce	induce	VB	I-VP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
specific	specific	JJ	I-NP	O
complex	complex	NN	I-NP	O
(	(	(	O	O
complex	complex	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
represents	represent	VBZ	B-VP	O
the	the	DT	B-NP	O
p50/65	p50/65	NN	I-NP	B-protein
heterodimer	heterodimer	NN	I-NP	I-protein
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
Mono	Mono	NN	B-NP	B-cell_line
Mac	Mac	NN	I-NP	I-cell_line
6	6	CD	B-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
pyrrolidine-dithiocarbamate	pyrrolidine-dithiocarbamate	NN	B-NP	O
(	(	(	O	O
PDTC	PDTC	NN	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
300	300	CD	B-NP	O
microM	microM	NN	I-NP	O
will	will	MD	B-VP	O
block	block	VB	I-VP	O
the	the	DT	B-NP	O
LPS-induced	LPS-induced	JJ	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
I	I	PRP	B-NP	O
almost	almost	RB	B-ADVP	O
completely	completely	RB	I-ADVP	O
and	and	CC	O	O
will	will	MD	B-VP	O
reduce	reduce	VB	I-VP	O
complex	complex	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

Binding	Binding	NN	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
recognize	recognize	VBP	B-VP	O
the	the	DT	B-NP	O
SP-1	SP-1	NN	I-NP	B-protein
and	and	CC	I-NP	O
c/EBP	c/EBP	NN	I-NP	B-protein
motifs	motif	NNS	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
TNF	TNF	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
such	such	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
PDTC	PDTC	NN	B-NP	O
treatment	treatment	NN	I-NP	O
will	will	MD	B-VP	O
strongly	strongly	RB	I-VP	O
reduce	reduce	VB	I-VP	O
LPS-induced	LPS-induced	JJ	B-NP	B-RNA
TNF	TNF	NN	I-NP	I-RNA
transcripts	transcript	NNS	I-NP	I-RNA
.	.	.	O	O

Secreted	Secrete	VBN	B-NP	O
TNF	TNF	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
as	as	IN	B-SBAR	O
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Wehi	Wehi	NNP	I-NP	O
164S/ActD	164S/ActD	NN	I-NP	O
bioassay	bioassay	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
sandwich	sandwich	JJ	I-NP	O
immunoassay	immunoassay	NN	I-NP	O
was	be	VBD	B-VP	O
similarly	similarly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
by	by	IN	B-PP	O
PDTC	PDTC	NN	B-NP	O
.	.	.	O	O

Kinetic	Kinetic	JJ	B-NP	O
analyses	analysis	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
after	after	IN	B-SBAR	O
LPS	LPS	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
,	,	,	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
will	will	MD	B-VP	O
peak	peak	VB	I-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
TNF	TNF	NN	B-NP	B-protein
transcript	transcript	NN	I-NP	O
prevalence	prevalence	NN	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
TNF	TNF	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
at	at	IN	B-PP	O
4	4	CD	B-NP	O
h	h	NN	I-NP	O
.	.	.	O	O

PDTC	PDTC	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
shift	shift	VB	I-VP	O
this	this	DT	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
LPS	LPS	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
suppressed	suppress	VBD	B-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
mobilization	mobilization	NN	I-NP	O
,	,	,	O	O
TNF	TNF	NN	B-NP	B-RNA
transcripts	transcript	NNS	I-NP	I-RNA
,	,	,	O	O
and	and	CC	O	O
TNF	TNF	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
over	over	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
8-h	8-h	JJ	I-NP	O
observation	observation	NN	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
freshly	freshly	RB	B-NP	O
isolated	isolate	VBN	I-NP	O
,	,	,	I-NP	O
LPS-stimulated	LPS-stimulated	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
blockade	blockade	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
primary	primary	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
TNF	TNF	NN	B-NP	B-RNA
transcripts	transcript	NNS	I-NP	I-RNA
,	,	,	O	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
quantitative	quantitative	JJ	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
prevented	prevent	VBN	I-VP	O
by	by	IN	B-PP	O
PDTC	PDTC	NN	B-NP	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
TNF	TNF	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
production	production	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
dithiocarbamates	dithiocarbamate	NNS	B-NP	O
can	can	MD	B-VP	O
profoundly	profoundly	RB	I-VP	O
affect	affect	VB	I-VP	O
cytokine	cytokine	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
LPS-induced	LPS-induced	JJ	B-NP	O
TNF	TNF	NN	I-NP	B-protein
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Comparing	Compare	VBG	B-VP	O
regions	region	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Epstein-Barr	Epstein-Barr	JJ	I-NP	B-protein
virus	virus	NN	I-NP	I-protein
ZEBRA	ZEBRA	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
which	which	WDT	B-NP	O
function	function	VBP	B-VP	O
as	as	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	B-DNA
activating	activate	VBG	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
ZEBRA	ZEBRA	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
activates	activate	VBZ	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	B-DNA
virus	virus	NN	I-NP	I-DNA
early-lytic-cycle	early-lytic-cycle	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Here	Here	RB	B-ADVP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
ZEBRA	ZEBRA	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
behaves	behave	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
sequence-specific	sequence-specific	JJ	I-NP	B-protein
transcriptional	transcriptional	JJ	I-NP	I-protein
activator	activator	NN	I-NP	I-protein
in	in	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
.	.	.	O	O

Deletional	Deletional	JJ	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
defined	define	VBD	B-VP	O
three	three	CD	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
ZEBRA	ZEBRA	NN	B-NP	B-protein
that	that	WDT	B-NP	O
participate	participate	VBP	B-VP	O
in	in	IN	B-PP	O
activation	activation	NN	B-NP	O
in	in	IN	B-PP	O
S.	S.	FW	B-NP	O
cerevisiae	cerevisiae	FW	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
regions	region	NNS	I-NP	O
are	be	VBP	B-VP	O
designated	designate	VBN	I-VP	O
YI	YI	NN	B-NP	O
(	(	(	O	O
amino	amino	JJ	B-NP	O
acids	acid	NNS	I-NP	O
[	[	(	O	O
aa	aa	NNS	B-NP	O
]	]	)	O	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
25	25	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
YII	YII	NN	B-NP	B-protein
(	(	(	O	O
aa	aa	NNS	B-NP	O
51	51	CD	B-NP	O
to	to	TO	B-PP	O
102	102	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
YIII	YIII	NN	B-NP	B-protein
(	(	(	O	O
aa	aa	NNS	B-NP	O
228	228	CD	B-NP	O
to	to	TO	B-PP	O
245	245	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Two	Two	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
native	native	JJ	I-NP	B-protein
ZEBRA	ZEBRA	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
act	act	VBP	B-VP	O
together	together	RB	B-ADVP	O
to	to	TO	B-VP	O
mediate	mediate	VB	I-VP	O
activation	activation	NN	B-NP	O
when	when	WRB	B-ADVP	O
assayed	assay	VBN	B-VP	O
on	on	IN	B-PP	O
ZEBRA	ZEBRA	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
fused	fuse	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
GAL	GAL	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
and	and	CC	O	O
assayed	assay	VBN	B-VP	O
on	on	IN	B-PP	O
GAL4	GAL4	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
regions	region	NNS	B-NP	O
YII	YII	NN	I-NP	B-protein
and	and	CC	I-NP	O
YIII	YIII	NN	I-NP	B-protein
were	be	VBD	B-VP	O
each	each	DT	O	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
confer	confer	VB	I-VP	O
activation	activation	NN	B-NP	O
in	in	IN	B-PP	O
S.	S.	FW	B-NP	O
cerevisiae	cerevisiae	FW	I-NP	O
.	.	.	O	O

Regions	Region	NNS	B-NP	O
of	of	IN	B-PP	O
ZEBRA	ZEBRA	NN	B-NP	B-protein
which	which	WDT	B-NP	O
affected	affect	VBD	B-VP	O
activation	activation	NN	B-NP	O
in	in	IN	B-PP	O
S.	S.	FW	B-NP	O
cerevisiae	cerevisiae	FW	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
required	require	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
amino-terminal	amino-terminal	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
of	of	IN	B-PP	O
ZEBRA	ZEBRA	NN	B-NP	B-protein
(	(	(	O	O
aa	aa	NNS	B-NP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
98	98	CD	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
activation	activation	NN	B-NP	O
both	both	CC	B-PP	O
in	in	IN	B-PP	O
S.	S.	FW	B-NP	O
cerevisiae	cerevisiae	FW	I-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
;	;	:	O	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
carboxy-terminal	carboxy-terminal	JJ	I-NP	B-protein
18	18	CD	I-NP	I-protein
aa	aa	NN	I-NP	I-protein
also	also	RB	B-ADVP	O
significantly	significantly	RB	B-VP	O
reduced	reduce	VBD	I-VP	O
activation	activation	NN	B-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
behavior	behavior	NN	I-NP	O
of	of	IN	B-PP	O
ZEBRA	ZEBRA	NN	B-NP	B-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
S.	S.	FW	B-NP	O
cerevisiae	cerevisiae	FW	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
contains	contain	VBZ	B-VP	O
universal	universal	JJ	B-NP	B-DNA
activation	activation	NN	I-NP	I-DNA
motifs	motif	NNS	I-NP	I-DNA
that	that	WDT	B-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
conserved	conserve	VBN	B-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
machinery	machinery	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
certain	certain	JJ	B-NP	O
deletion	deletion	NN	I-NP	O
mutants	mutant	NNS	I-NP	O
of	of	IN	B-PP	O
ZEBRA	ZEBRA	NN	B-NP	B-protein
containing	contain	VBG	B-VP	O
mutations	mutation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
exhibited	exhibit	VBD	B-VP	O
discordant	discordant	JJ	B-NP	O
behaviors	behavior	NNS	I-NP	O
in	in	IN	B-PP	O
S.	S.	FW	B-NP	O
cerevisiae	cerevisiae	FW	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

For	For	IN	B-PP	O
example	example	NN	B-NP	O
,	,	,	O	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
ZEBRA	ZEBRA	NN	B-NP	B-protein
aa	aa	NNS	I-NP	I-protein
26	26	CD	B-NP	I-protein
to	to	TO	B-PP	O
51	51	CD	B-NP	O
impaired	impaired	JJ	I-NP	O
activation	activation	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
great	great	JJ	I-NP	O
extent	extent	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
but	but	CC	O	O
had	have	VBD	B-VP	O
little	little	JJ	B-NP	O
or	or	CC	I-NP	O
no	no	DT	I-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
S.	S.	FW	B-NP	O
cerevisiae	cerevisiae	FW	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
discordant	discordant	JJ	I-NP	O
mutants	mutant	NNS	I-NP	O
may	may	MD	B-VP	O
reflect	reflect	VB	I-VP	O
interactions	interaction	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
variable	variable	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
component	component	NN	I-NP	O
or	or	CC	O	O
unique	unique	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
with	with	IN	B-PP	O
specialized	specialize	VBN	B-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
apparatus	apparatus	NN	I-NP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Functional	Functional	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
v-Rel	v-Rel	NN	I-NP	B-protein
and	and	CC	I-NP	O
c-Rel	c-Rel	NN	I-NP	B-protein
oncoproteins	oncoprotein	NNS	I-NP	I-protein
with	with	IN	B-PP	O
the	the	DT	B-NP	O
TATA-binding	TATA-binding	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
and	and	CC	I-NP	O
association	association	NN	I-NP	O
with	with	IN	B-PP	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
IIB	IIB	NN	I-NP	O
.	.	.	O	O

Rel	Rel	NN	B-NP	B-protein
family	family	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
regulate	regulate	VBP	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
kappa	kappa	NN	B-NP	B-DNA
B-binding	B-binding	JJ	I-NP	I-DNA
motifs	motif	NNS	I-NP	I-DNA
.	.	.	O	O

Little	Little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
they	they	PRP	B-NP	O
enhance	enhance	VBP	B-VP	O
transcription	transcription	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
investigated	investigate	VBN	I-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
v-Rel	v-Rel	NN	I-NP	B-protein
and	and	CC	I-NP	O
c-Rel	c-Rel	NN	I-NP	B-protein
oncoproteins	oncoprotein	NNS	I-NP	I-protein
to	to	TO	B-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
components	component	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
machinery	machinery	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
the	the	DT	B-NP	O
acidic	acidic	JJ	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
activation	activation	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
mapping	map	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
unique	unique	JJ	I-NP	O
C	C	NN	I-NP	B-protein
terminus	terminus	NN	I-NP	I-protein
of	of	IN	B-PP	O
chicken	chicken	NN	B-NP	B-protein
c-Rel	c-Rel	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
F9	F9	NN	I-NP	O
cell-specific	cell-specific	JJ	I-NP	O
activation	activation	NN	I-NP	O
region	region	NN	I-NP	O
common	common	JJ	B-ADJP	O
to	to	TO	B-PP	O
both	both	CC	O	O
v-Rel	v-Rel	NN	B-NP	B-protein
and	and	CC	I-NP	O
c-Rel	c-Rel	NN	I-NP	B-protein
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
TATA-binding	TATA-binding	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
TBP	TBP	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
transcription	transcription	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
IIB	IIB	NN	I-NP	O
(	(	(	O	O
TFIIB	TFIIB	NN	B-NP	B-protein
)	)	)	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
TPB	TPB	NN	B-NP	B-protein
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
Rel	Rel	NN	B-NP	B-protein
activation	activation	NN	I-NP	I-protein
regions	region	NNS	I-NP	I-protein
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
synergistic	synergistic	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B-linked	B-linked	JJ	I-NP	I-DNA
reporter	reporter	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

Combined	Combine	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
observation	observation	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
c-Rel	c-Rel	NN	I-NP	B-protein
and	and	CC	O	O
human	human	JJ	B-NP	B-protein
RelA	RelA	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
also	also	RB	B-ADVP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
TBP	TBP	NN	B-NP	B-protein
and	and	CC	I-NP	O
TFIIB	TFIIB	NN	I-NP	B-protein
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
basal	basal	JJ	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
Rel	Rel	NN	B-NP	B-protein
family	family	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

p21ras	p21ras	NN	B-NP	B-protein
and	and	CC	I-NP	O
calcineurin	calcineurin	NN	I-NP	B-protein
synergize	synergize	VBP	B-VP	O
to	to	TO	I-VP	O
regulate	regulate	VB	I-VP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
of	of	IN	B-PP	I-protein
activated	activate	VBN	B-NP	I-protein
T	T	NN	I-NP	I-protein
cells	cell	NNS	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
triggering	trigger	VBG	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
TCR	TCR	NN	B-NP	B-protein
)	)	)	O	O
induces	induce	VBZ	B-VP	O
several	several	JJ	B-NP	O
signaling	signal	VBG	I-NP	O
cascades	cascade	NNS	I-NP	O
which	which	WDT	B-NP	O
ultimately	ultimately	RB	B-ADVP	O
synergize	synergize	VBP	B-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
of	of	IN	B-PP	I-protein
activated	activate	VBN	B-NP	I-protein
T	T	NN	I-NP	I-protein
cells	cell	NNS	I-NP	I-protein
(	(	(	O	O
NFAT	NFAT	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
critical	critical	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inducibility	inducibility	NN	I-NP	O
and	and	CC	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
interleukin	interleukin	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

One	One	CD	B-NP	O
immediate	immediate	JJ	I-NP	O
consequence	consequence	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
TCR	TCR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
cytosolic	cytosolic	JJ	B-NP	O
calcium	calcium	NN	I-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
signals	signal	NNS	I-NP	O
are	be	VBP	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
NFAT	NFAT	NN	B-NP	B-protein
induction	induction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
calcineurin	calcineurin	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
calcium-calmodulin	calcium-calmodulin	NN	I-NP	B-protein
dependent	dependent	JJ	I-NP	O
serine-threonine	serine-threonine	NN	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
prominent	prominent	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
calcium	calcium	NN	I-NP	O
signaling	signaling	NN	I-NP	O
pathway	pathway	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

A	A	DT	B-NP	O
second	second	JJ	I-NP	O
important	important	JJ	I-NP	O
molecule	molecule	NN	I-NP	O
in	in	IN	B-PP	O
TCR	TCR	NN	B-NP	B-protein
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
guanine	guanine	NN	I-NP	B-protein
nucleotide	nucleotide	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
p21ras	p21ras	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
coupled	couple	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
TCR	TCR	NN	I-NP	B-protein
by	by	IN	B-PP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
dependent	dependent	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
experiments	experiment	NNS	I-NP	O
presented	present	VBN	B-VP	O
here	here	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
by	by	IN	B-PP	O
transfection	transfection	NN	B-NP	O
of	of	IN	B-PP	O
mutationally	mutationally	RB	B-NP	O
activated	activate	VBN	I-NP	O
calcineurin	calcineurin	NN	I-NP	B-protein
or	or	CC	O	O
activated	activate	VBN	B-NP	O
p21ras	p21ras	NN	I-NP	B-protein
alone	alone	RB	B-ADVP	O
is	be	VBZ	B-VP	O
insufficient	insufficient	JJ	B-ADJP	O
for	for	IN	B-PP	O
NFAT	NFAT	NN	B-NP	B-protein
transactivation	transactivation	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
coexpression	coexpression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
activated	activate	VBN	I-NP	O
calcineurin	calcineurin	NN	I-NP	B-protein
with	with	IN	B-PP	O
activated	activate	VBN	B-NP	O
p21ras	p21ras	NN	I-NP	B-protein
could	could	MD	B-VP	O
mimic	mimic	VB	I-VP	O
TCR	TCR	NN	B-NP	B-protein
signals	signal	NNS	I-NP	O
in	in	IN	B-PP	O
NFAT	NFAT	NN	B-NP	B-protein
induction	induction	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
identify	identify	VBP	B-VP	O
calcineurin	calcineurin	NN	B-NP	B-protein
and	and	CC	I-NP	O
p21ras	p21ras	NN	I-NP	B-protein
as	as	IN	B-PP	O
cooperative	cooperative	JJ	B-NP	O
partners	partner	NNS	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chicken	chicken	NN	I-NP	B-protein
GATA	GATA	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
during	during	IN	B-PP	O
early	early	JJ	B-NP	O
erythroid	erythroid	JJ	I-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
DNA	DNA	NN	I-NP	O
motif	motif	NN	I-NP	O
WGATAR	WGATAR	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
within	within	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	B-protein
regulatory	regulatory	JJ	I-NP	I-protein
domains	domain	NNS	I-NP	I-protein
of	of	IN	B-PP	O
globin	globin	NN	B-NP	B-protein
and	and	CC	O	O
other	other	JJ	B-NP	O
erythroid-specific	erythroid-specific	JJ	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
activator	activator	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
GATA	GATA	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
belong	belong	VBP	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
multi-gene	multi-gene	JJ	I-NP	B-protein
family	family	NN	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
chicken	chicken	NN	B-NP	B-cell_type
erythroid	erythroid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
chickens	chicken	NNS	B-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GATA	GATA	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
murine	murine	JJ	I-NP	I-cell_type
erythroid	erythroid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
chicken	chicken	NN	B-NP	O
embryogenesis	embryogenesis	NN	I-NP	O
(	(	(	O	O
well	well	RB	B-ADVP	O
before	before	IN	B-PP	O
blood	blood	NN	B-NP	O
island	island	NN	I-NP	O
formation	formation	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GATA	GATA	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
is	be	VBZ	B-VP	O
transcribed	transcribe	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
temporal	temporal	JJ	I-NP	O
and	and	CC	I-NP	O
spatial	spatial	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
primitive	primitive	JJ	I-NP	B-cell_type
erythroid	erythroid	JJ	I-NP	I-cell_type
lineage	lineage	NN	I-NP	I-cell_type
,	,	,	O	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
embryonic	embryonic	JJ	I-NP	B-DNA
epsilon-globin	epsilon-globin	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
parallels	parallel	VBZ	B-VP	O
GATA-1	GATA-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
switch	switch	NN	I-NP	O
to	to	TO	B-PP	O
beta-globin	beta-globin	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	O
in	in	IN	B-PP	O
definitive	definitive	JJ	B-NP	O
erythroid	erythroid	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
directly	directly	RB	I-VP	O
preceded	precede	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
pronounced	pronounced	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
GATA-3	GATA-3	NN	B-NP	B-protein
accumulation	accumulation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
timing	timing	NN	I-NP	O
and	and	CC	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
different	different	JJ	I-NP	O
mRNAs	mRNA	NNS	I-NP	B-RNA
during	during	IN	B-PP	O
avian	avian	JJ	B-NP	O
erythroid	erythroid	JJ	I-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
temporally	temporally	RB	B-NP	O
regulated	regulate	VBN	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
GATA	GATA	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
vertebrate	vertebrate	NN	B-NP	O
hematopoiesis	hematopoiesis	NN	I-NP	O
.	.	.	O	O

Molecular	Molecular	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
interleukin	interleukin	NN	I-NP	O
2	2	CD	I-NP	O
and	and	CC	I-NP	O
T-cell	T-cell	NN	I-NP	O
function	function	NN	I-NP	O
by	by	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Distinct	Distinct	JJ	B-NP	B-cell_type
functional	functional	JJ	I-NP	I-cell_type
T-cell	T-cell	NN	I-NP	I-cell_type
subsets	subset	NNS	I-NP	I-cell_type
,	,	,	O	O
differing	differ	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
lymphokines	lymphokine	NNS	B-NP	B-protein
produced	produce	VBN	B-VP	O
,	,	,	O	O
regulate	regulate	VBP	B-VP	O
cell-mediated	cell-mediated	JJ	B-NP	O
and	and	CC	I-NP	O
humoral	humoral	JJ	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
two	two	CD	I-NP	O
major	major	JJ	I-NP	O
types	type	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
principal	principal	JJ	I-NP	O
products	product	NNS	I-NP	O
,	,	,	O	O
interleukin	interleukin	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
and	and	CC	O	O
interferon	interferon	NN	B-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
(	(	(	O	O
IL-4	IL-4	NN	B-NP	B-protein
and	and	CC	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
are	be	VBP	B-VP	O
reciprocally	reciprocally	RB	B-ADVP	O
negatively	negatively	RB	B-ADJP	O
interactive	interactive	JJ	I-ADJP	O
.	.	.	O	O

To	To	TO	B-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
IL-4-mediated	IL-4-mediated	JJ	B-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
cell-mediated	cell-mediated	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
its	its	PRP$	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
(	(	(	O	O
IL-2	IL-2	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
.	.	.	O	O

IL-4	IL-4	NN	B-NP	B-protein
pretreatment	pretreatment	NN	I-NP	O
of	of	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
stimulation	stimulation	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL2	IL2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

IL-4	IL-4	NN	B-NP	B-protein
suppressed	suppress	VBD	B-VP	O
IL-2	IL-2	NN	B-NP	B-protein
and	and	CC	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
anti-CD28	anti-CD28	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
relieved	relieve	VBD	B-VP	O
this	this	DT	B-NP	O
suppression	suppression	NN	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
enhancer-reporter	enhancer-reporter	JJ	B-NP	B-DNA
constructs	construct	NNS	I-NP	I-DNA
,	,	,	O	O
IL-4	IL-4	NN	B-NP	B-protein
specifically	specifically	RB	B-ADVP	O
down-regulated	down-regulate	VBD	B-VP	O
the	the	DT	B-NP	O
NFIL-2B	NFIL-2B	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	O
oligomer	oligomer	NN	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
NFIL-2B	NFIL-2B	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
IL-4	IL-4	NN	B-NP	B-protein
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
NFIL-2B	NFIL-2B	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
NFIL-2B	NFIL-2B	NN	I-NP	B-protein
DNA	DNA	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
AP-	AP-	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
IL-4	IL-4	NN	B-NP	B-protein
may	may	MD	B-VP	O
regulate	regulate	VB	I-VP	O
development	development	NN	B-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
T-cell	T-cell	NN	B-NP	B-cell_type
subsets	subset	NNS	I-NP	I-cell_type
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
cell-mediated	cell-mediated	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	B-protein
factors	factor	NNS	B-NP	I-protein
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IL2	IL2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA

Immunochemical	Immunochemical	JJ	B-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
from	from	IN	B-PP	O
corticoid-sensitive	corticoid-sensitive	JJ	B-NP	O
and	and	CC	I-NP	O
-resistant	-resistant	JJ	I-NP	B-cell_line
malignant	malignant	JJ	I-NP	I-cell_line
lymphocytes	lymphocyte	NNS	I-NP	I-cell_line
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
explored	explore	VBN	I-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
using	use	VBG	B-VP	O
antibodies	antibody	NNS	B-NP	B-protein
against	against	IN	B-PP	O
purified	purify	VBN	B-NP	O
rat	rat	NN	I-NP	O
liver	liver	NN	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
to	to	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
immunochemical	immunochemical	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
from	from	IN	B-PP	O
murine	murine	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
human	human	JJ	I-NP	I-cell_type
malignant	malignant	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
purpose	purpose	NN	I-NP	O
,	,	,	O	O
purified	purify	VBN	B-VP	O
immune	immune	JJ	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	O
G	G	NN	I-NP	O
was	be	VBD	B-VP	O
covalently	covalently	RB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
Sepharose	Sepharose	NN	B-NP	B-protein
CL-4B	CL-4B	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
then	then	RB	B-ADVP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
affinity	affinity	NN	I-NP	O
gel	gel	NN	I-NP	O
to	to	TO	B-VP	O
recognize	recognize	VB	I-VP	O
cytosolic	cytosolic	JJ	B-NP	B-protein
[	[	(	I-NP	I-protein
3H	3H	NN	I-NP	I-protein
]	]	)	I-NP	I-protein
triamcinolone	triamcinolone	NN	I-NP	I-protein
acetonide-receptor	acetonide-receptor	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
corticoid-sensitive	corticoid-sensitive	JJ	I-NP	O
(	(	(	O	O
CS	CS	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
-resistant	-resistant	JJ	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
P1798	P1798	NN	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
CS	CS	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
lymphatic	lymphatic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
CS	CS	JJ	I-NP	B-cell_line
clone	clone	NN	I-NP	I-cell_line
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
leukemic	leukemic	JJ	I-NP	I-cell_type
lymphoblasts	lymphoblast	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
tissue	tissue	NN	B-NP	O
culture	culture	NN	I-NP	O
(	(	(	O	O
CH6	CH6	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Mouse	Mouse	NN	B-NP	O
thymus	thymus	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
CS	CS	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Whereas	Whereas	IN	B-SBAR	O
the	the	DT	B-NP	O
immunoaffinity	immunoaffinity	NN	I-NP	O
column	column	NN	I-NP	O
retained	retain	VBD	B-VP	O
70	70	CD	B-NP	O
to	to	TO	B-PP	O
84	84	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
58-	58-	CD	I-NP	O
to	to	TO	B-PP	O
62-A	62-A	NN	B-NP	O
(	(	(	O	O
Stokes	Stokes	NNP	B-NP	O
radius	radius	NN	I-NP	O
)	)	)	O	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	I-NP	O
triamcinolone	triamcinolone	NN	I-NP	B-protein
acetonide-receptor	acetonide-receptor	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CS	CS	JJ	I-NP	O
mouse	mouse	NN	I-NP	O
and	and	CC	O	O
human	human	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
it	it	PRP	B-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
recognize	recognize	VB	I-VP	O
the	the	DT	B-NP	O
27-	27-	CD	I-NP	O
to	to	TO	B-PP	O
28-A	28-A	NN	B-NP	O
(	(	(	O	O
Stokes	Stokes	NNP	B-NP	O
radius	radius	NN	I-NP	O
)	)	)	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
corticoid-resistant	corticoid-resistant	JJ	B-NP	B-cell_line
mouse	mouse	NN	I-NP	I-cell_line
lymphoma	lymphoma	NN	I-NP	I-cell_line
P1798	P1798	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
under	under	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
experimental	experimental	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
possible	possible	JJ	B-ADJP	O
to	to	TO	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
cross-reactivity	cross-reactivity	NN	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
antiserum	antiserum	NN	I-NP	O
against	against	IN	B-PP	O
rat	rat	NN	B-NP	B-protein
liver	liver	NN	I-NP	I-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
58-	58-	CD	I-NP	O
to	to	TO	B-PP	O
62-A	62-A	NN	B-NP	O
(	(	(	O	O
Stokes	Stokes	NNP	B-NP	O
radius	radius	NN	I-NP	O
)	)	)	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
from	from	IN	B-PP	O
species	specie	NNS	B-NP	O
as	as	RB	B-ADJP	O
diverse	diverse	JJ	I-ADJP	O
as	as	IN	B-PP	O
mouse	mouse	NN	B-NP	O
and	and	CC	O	O
humans	human	NNS	B-NP	O
.	.	.	O	O

Heterogeneity	Heterogeneity	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
leukocyte	leukocyte	NN	B-NP	B-cell_type
population	population	NN	I-NP	I-cell_type
freshly	freshly	RB	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
26	26	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
measured	measure	VBN	I-VP	O
several	several	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
including	include	VBG	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
nucleoside	nucleoside	NN	B-NP	O
incorporation	incorporation	NN	I-NP	O
,	,	,	O	O
percentage	percentage	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
steroid-induced	steroid-induced	JJ	B-NP	O
cell	cell	NN	I-NP	O
lysis	lysis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
short-term	short-term	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
steroid	steroid	NN	B-NP	O
therapy	therapy	NN	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
,	,	,	O	O
in	in	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
patients	patient	NNS	I-NP	O
studied	study	VBN	B-VP	O
,	,	,	O	O
leukocytes	leukocyte	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
we	we	PRP	B-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
any	any	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-NP	B-protein
sites	site	NNS	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
or	or	CC	O	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
correlation	correlation	NN	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
explained	explain	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
marked	marked	JJ	I-NP	O
heterogeneity	heterogeneity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
steroid	steroid	NN	I-NP	O
response	response	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
in	in	IN	B-PP	O
leukocyte	leukocyte	NN	B-NP	B-cell_type
subpopulations	subpopulation	NNS	I-NP	I-cell_type
.	.	.	O	O

It	It	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
action	action	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
and	and	CC	I-NP	O
dexamethasone-induced	dexamethasone-induced	JJ	I-NP	O
cell	cell	NN	I-NP	O
death	death	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
S	S	NN	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
cytosol	cytosol	NN	B-NP	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	O
extract	extract	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Cortisol	Cortisol	NN	B-NP	O
binding	binding	NN	I-NP	O
by	by	IN	B-PP	O
cytosol	cytosol	NN	B-NP	O
and	and	CC	O	O
0.4	0.4	CD	B-NP	O
M	M	NN	I-NP	O
KCl	KCl	NN	I-NP	O
extract	extract	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
gel	gel	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
and	and	CC	O	O
ion	ion	NN	B-NP	O
exchange	exchange	NN	I-NP	O
filtration	filtration	NN	I-NP	O
on	on	IN	B-PP	O
DEAE	DEAE	NN	B-NP	O
cellulose	cellulose	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
cortisol	cortisol	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
weight	weight	NN	I-NP	O
95	95	CD	I-NP	O
000	000	CD	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
soluble	soluble	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
binding	bind	VBG	I-NP	O
protein	protein	NN	I-NP	O
50	50	CD	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
uptake	uptake	NN	I-NP	O
of	of	IN	B-PP	O
radioactive	radioactive	JJ	B-NP	O
cortisol	cortisol	NN	I-NP	O
by	by	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
nuclei	nucleus	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
requirement	requirement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytosol	cytosol	NN	I-NP	O
for	for	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
specific	specific	JJ	I-NP	O
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
receptor	receptor	NN	I-NP	O
sites	site	NNS	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
association	association	NN	I-NP	O
constant	constant	NN	I-NP	O
characterising	characterise	VBG	B-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
to	to	TO	B-PP	O
cytosol	cytosol	NN	B-NP	O
was	be	VBD	B-VP	O
KA	KA	NN	B-NP	O
=	=	SYM	B-VP	O
3.5	3.5	CD	B-NP	O
.	.	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
9	9	CD	B-NP	O
)	)	)	O	O
l/mol	l/mol	NN	B-NP	O
.	.	.	O	O

Corticosteroid-induced	Corticosteroid-induced	JJ	B-NP	O
lymphopenia	lymphopenia	NN	I-NP	O
,	,	,	O	O
immunosuppression	immunosuppression	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
body	body	NN	B-NP	O
defense	defense	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
paradox	paradox	NN	I-NP	O
of	of	IN	B-PP	O
heightened	heighten	VBN	B-NP	O
adrenal	adrenal	JJ	I-NP	O
corticosteroid	corticosteroid	NN	I-NP	O
levels	level	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
reduction	reduction	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
competence	competence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
's	's	POS	B-NP	O
defensive	defensive	JJ	I-NP	O
apparatus	apparatus	NN	I-NP	O
to	to	TO	B-VP	O
cope	cope	VB	I-VP	O
with	with	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
new	new	JJ	B-NP	O
microbial	microbial	JJ	I-NP	B-protein
antigens	antigen	NNS	I-NP	I-protein
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
question	question	NN	I-NP	O
is	be	VBZ	B-VP	O
asked	ask	VBN	I-VP	O
how	how	WRB	B-ADVP	O
this	this	DT	B-NP	O
lowered	lower	VBN	I-NP	O
defensive	defensive	JJ	I-NP	O
capability	capability	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
occurs	occur	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
face	face	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
threat	threat	NN	I-NP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
integrity	integrity	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
Cannon	Cannon	NNP	B-NP	O
's	's	POS	B-NP	O
principals	principal	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
``	``	``	I-NP	O
wisdom	wisdom	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
body.	body.	NN	I-NP	O
''	''	''	O	O

The	The	DT	B-NP	O
suggestion	suggestion	NN	I-NP	O
is	be	VBZ	B-VP	O
offered	offer	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
immunologic	immunologic	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
self-antigens	self-antigen	NNS	B-NP	B-protein
exposed	expose	VBN	B-VP	O
by	by	IN	B-PP	O
disease	disease	NN	B-NP	O
or	or	CC	I-NP	O
trauma	trauma	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
suppressed	suppress	VBN	I-VP	O
by	by	IN	B-PP	O
corticosteroid	corticosteroid	NN	B-NP	O
to	to	TO	B-VP	O
offset	offset	VB	I-VP	O
the	the	DT	B-NP	O
likelihood	likelihood	NN	I-NP	O
of	of	IN	B-PP	O
autoimmune	autoimmune	JJ	B-NP	O
attack	attack	NN	I-NP	O
.	.	.	O	O

Protein	Protein	NN	B-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
LPS	LPS	NN	I-NP	O
induce	induce	VBP	B-VP	O
production	production	NN	B-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
IL-1	IL-1	NN	B-NP	B-protein
,	,	,	O	O
IL-6	IL-6	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
TNF	TNF	NN	B-NP	B-protein
in	in	IN	B-PP	O
mononuclear	mononuclear	JJ	B-NP	B-cell_type
phagocytes	phagocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
component	component	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
septic	septic	JJ	B-NP	O
shock	shock	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
LPS	LPS	NN	B-NP	O
activates	activate	VBZ	B-VP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
to	to	TO	B-VP	O
express	express	VB	I-VP	O
cytokines	cytokine	NNS	B-NP	B-protein
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
completely	completely	RB	I-VP	O
characterized	characterize	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
addressed	address	VBD	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
protein	protein	NN	I-NP	B-protein
kinases	kinase	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
LPS	LPS	NN	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
LPS	LPS	NN	B-NP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
12-	12-	CD	I-NP	O
to	to	TO	B-PP	O
16-fold	16-fold	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
IL-1	IL-1	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
,	,	,	O	O
IL-6	IL-6	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
completely	completely	RB	B-ADVP	O
or	or	CC	O	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
blocked	block	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
specific	specific	JJ	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
herbimycin	herbimycin	NN	I-NP	O
A	A	NN	I-NP	O
and	and	CC	O	O
genistein	genistein	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
and	and	CC	I-NP	O
37	37	CD	I-NP	O
microM	microM	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Protein	Protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
inhibition	inhibition	NN	I-NP	O
by	by	IN	B-PP	O
staurosporine	staurosporine	NN	B-NP	O
reduced	reduce	VBD	B-VP	O
LPS	LPS	NN	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
,	,	,	O	O
whereas	whereas	IN	O	O
it	it	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
IL-6	IL-6	NN	B-NP	B-protein
and	and	CC	O	O
IL-1	IL-1	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
by	by	IN	B-PP	O
H89	H89	NN	B-NP	B-protein
reduced	reduce	VBD	B-VP	O
IL-6	IL-6	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
detectably	detectably	RB	I-VP	O
change	change	VB	I-VP	O
IL-1	IL-1	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
or	or	CC	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
LPS	LPS	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
increase	increase	VB	I-VP	O
leukemia	leukemia	NN	B-NP	B-RNA
inhibitory	inhibitory	JJ	I-NP	I-RNA
factor	factor	NN	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
constitutively	constitutively	RB	I-VP	O
expressed	express	VBN	I-VP	O
and	and	CC	O	O
not	not	RB	B-VP	O
significantly	significantly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
by	by	IN	B-PP	O
these	these	DT	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
cytokine	cytokine	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
,	,	,	O	O
LPS-induced	LPS-induced	JJ	B-NP	O
IL-6	IL-6	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
synthesis	synthesis	NN	I-NP	O
and	and	CC	O	O
IL-6	IL-6	NN	B-NP	B-protein
bioactivity	bioactivity	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
levels	level	NNS	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
PTK	PTK	NN	I-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	O
herbimycin	herbimycin	NN	I-NP	O
A	A	NN	I-NP	O
and	and	CC	I-NP	O
genistein	genistein	NN	I-NP	O
.	.	.	O	O

Both	Both	DT	B-NP	O
PTK	PTK	NN	I-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	O
also	also	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
LPS	LPS	NN	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor-kappa	factor-kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
(	(	(	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
IL-6	IL-6	NN	B-NP	B-protein
and	and	CC	I-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
by	by	IN	B-PP	O
H89	H89	NN	B-NP	B-protein
,	,	,	O	O
whereas	whereas	IN	O	O
staurosporine	staurosporine	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
and	and	CC	O	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
selective	selective	JJ	B-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
LPS	LPS	NN	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
,	,	,	O	O
whereas	whereas	IN	O	O
PTK	PTK	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
LPS	LPS	NN	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
broad	broad	JJ	I-NP	O
spectrum	spectrum	NN	I-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
and	and	CC	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

In	In	FW	B-NP	O
vivo	vivo	FW	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
stored	store	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O
in	in	IN	B-PP	O
complexes	complex	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
protein	protein	NN	I-NP	O
I	I	NN	I-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
that	that	IN	B-SBAR	O
dissociation	dissociation	NN	B-NP	O
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
from	from	IN	B-PP	O
these	these	DT	B-NP	O
complexes	complex	NNS	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
active	active	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
)	)	)	O	O
-induced	-induced	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	O
or	or	CC	O	O
pre-B	pre-B	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
from	from	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

Many	Many	JJ	B-NP	O
liberated	liberate	VBN	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
dimers	dimer	NNS	I-NP	I-protein
reached	reach	VBD	B-VP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
increased	increase	VBN	B-NP	O
c-rel	c-rel	NN	I-NP	B-protein
,	,	,	O	O
p65	p65	NN	B-NP	B-protein
and	and	CC	O	O
p50	p50	NN	B-NP	B-protein
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
immunoblotting	immunoblotting	NN	B-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
liberated	liberate	VBN	I-NP	O
dimers	dimer	NNS	I-NP	O
were	be	VBD	B-VP	O
retained	retain	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
through	through	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
newly	newly	RB	B-NP	O
synthesized	synthesize	VBN	I-NP	O
I	I	NN	I-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
finding	finding	NN	I-NP	O
which	which	WDT	B-NP	O
strongly	strongly	RB	B-VP	O
suggests	suggest	VBZ	I-VP	O
(	(	(	O	O
i	i	NN	B-NP	O
)	)	)	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
LPS-induced	LPS-induced	JJ	I-NP	O
signal	signal	NN	I-NP	O
causes	cause	VBZ	B-VP	O
dissociation	dissociation	NN	B-NP	O
of	of	IN	B-PP	O
complexes	complex	NNS	B-NP	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
preventing	prevent	VBG	B-VP	O
their	their	PRP$	B-NP	O
association	association	NN	I-NP	O
and	and	CC	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
that	that	IN	B-SBAR	O
dissociation	dissociation	NN	B-NP	O
results	result	VBZ	B-VP	O
from	from	IN	B-PP	O
modification	modification	NN	B-NP	O
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
and	and	CC	B-PP	O
not	not	RB	B-PP	O
of	of	IN	I-PP	O
c-rel	c-rel	NN	B-NP	B-protein
or	or	CC	I-NP	O
p65	p65	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
LPS	LPS	NN	B-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
on	on	IN	B-PP	O
p105	p105	NN	B-NP	B-protein
or	or	CC	I-NP	O
p100	p100	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
also	also	RB	B-ADVP	O
retain	retain	VBP	B-VP	O
rel	rel	NN	B-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O
.	.	.	O	O

Quite	Quite	RB	B-ADVP	O
unexpectedly	unexpectedly	RB	I-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
also	also	RB	B-ADVP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
unstimulated	unstimulated	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
constant	constant	JJ	I-NP	O
ongoing	ongoing	JJ	I-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
degradation	degradation	NN	B-NP	O
and	and	CC	I-NP	O
replacement	replacement	NN	I-NP	O
of	of	IN	B-PP	O
complexed	complexe	VBN	B-NP	O
I	I	NN	I-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
turnover	turnover	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
presumably	presumably	RB	B-ADJP	O
necessary	necessary	JJ	I-ADJP	O
even	even	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
unstimulated	unstimulated	JJ	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
synthesis	synthesis	NN	B-NP	O
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
provides	provide	VBZ	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
turn	turn	VB	I-VP	O
off	off	RP	B-PRT	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
rapidly	rapidly	RB	B-ADVP	O
as	as	RB	B-ADVP	O
soon	soon	RB	I-ADVP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
activating	activate	VBG	I-NP	O
signal	signal	NN	I-NP	B-protein
ceases	cease	NNS	I-NP	I-protein
.	.	.	O	O

Identification	Identification	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
killer	killer	NN	I-NP	B-DNA
cell-specific	cell-specific	JJ	I-NP	I-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
perforin	perforin	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
:	:	:	O	O
an	an	DT	B-NP	O
Ets-binding	Ets-binding	JJ	I-NP	B-DNA
site-homologous	site-homologous	JJ	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
Ets-related	Ets-related	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
cytolytic	cytolytic	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
perforin	perforin	NN	I-NP	O
is	be	VBZ	B-VP	O
selectively	selectively	RB	I-VP	O
expressed	express	VBN	I-VP	O
by	by	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
killer	killer	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

To	To	TO	B-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
underlying	underlie	VBG	B-VP	O
the	the	DT	B-NP	O
cell-type-specific	cell-type-specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
characterized	characterize	VBN	I-VP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
functions	function	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
DNA-protein	DNA-protein	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
5'-flanking	5'-flanking	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
perforin	perforin	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
(	(	(	O	O
Pfp	Pfp	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
region	region	NN	I-NP	O
extending	extend	VBG	B-VP	O
from	from	IN	B-PP	O
residues	residue	NNS	B-NP	O
+62	+62	CD	B-NP	O
through	through	IN	B-PP	O
-141	-141	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
possesses	possess	VBZ	B-VP	O
the	the	DT	B-NP	O
essential	essential	JJ	I-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
regions	region	NNS	B-NP	O
further	further	RBR	B-ADVP	O
upstream	upstream	RB	I-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-PP	O
either	either	CC	O	O
enhance	enhance	VBP	B-VP	O
or	or	CC	I-VP	O
suppress	suppress	VBP	I-VP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
region	region	NN	I-NP	O
between	between	IN	B-PP	O
residues	residue	NNS	B-NP	O
-411	-411	CD	B-NP	O
and	and	CC	I-NP	O
-566	-566	CD	I-NP	O
was	be	VBD	B-VP	O
chosen	choose	VBN	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
characterization	characterization	NN	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
it	it	PRP	B-NP	O
contains	contain	VBZ	B-VP	O
an	an	DT	B-NP	O
enhancer-like	enhancer-like	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
a	a	DT	B-NP	O
32-mer	32-mer	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
(	(	(	O	O
residues	residue	NNS	B-NP	O
-491	-491	CD	B-NP	O
to	to	TO	B-PP	O
-522	-522	CD	B-NP	O
)	)	)	O	O
which	which	WDT	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
enhancing	enhance	VBG	B-VP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
killer	killer	NN	I-NP	O
cell-specific	cell-specific	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

Within	Within	IN	B-PP	O
this	this	DT	B-NP	O
segment	segment	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
9-mer	9-mer	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
(	(	(	O	O
5'-ACAGGAAGT-3	5'-ACAGGAAGT-3	NN	B-NP	B-DNA
'	'	''	O	I-DNA
,	,	,	O	O
residues	residue	NNS	B-NP	O
-505	-505	CD	B-NP	O
to	to	TO	B-PP	O
-497	-497	CD	B-NP	O
;	;	:	O	O
designated	designate	VBN	B-NP	O
NF-P	NF-P	NN	I-NP	B-protein
motif	motif	NN	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
highly	highly	RB	B-ADJP	O
homologous	homologous	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ets	Ets	NN	I-NP	B-DNA
proto-oncoprotein-binding	proto-oncoprotein-binding	JJ	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
NF-P1	NF-P1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NF-P2	NF-P2	NN	I-NP	B-protein
.	.	.	O	O

NF-P2	NF-P2	NN	B-NP	B-protein
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
reagents	reagent	NNS	B-NP	O
known	know	VBN	B-VP	O
to	to	TO	B-VP	O
up-regulate	up-regulate	VB	I-VP	O
the	the	DT	B-NP	O
perforin	perforin	NN	I-NP	O
message	message	NN	I-NP	O
level	level	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
exclusively	exclusively	RB	B-ADVP	O
in	in	IN	B-PP	O
killer	killer	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assay	assay	NN	I-NP	O
and	and	CC	O	O
UV	UV	NN	B-NP	O
cross-linking	cross-linking	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
NF-P1	NF-P1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NF-P2	NF-P2	NN	I-NP	B-protein
may	may	MD	B-VP	O
possess	possess	VB	I-VP	O
common	common	JJ	B-NP	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein
subunits	subunit	NNS	I-NP	I-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
larger	large	JJR	I-NP	O
native	native	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
mass	mass	NN	I-NP	O
of	of	IN	B-PP	O
NF-P1	NF-P1	NN	B-NP	B-protein
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
NF-P1	NF-P1	NN	B-NP	B-protein
contains	contain	VBZ	B-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
non-DNA-binding	non-DNA-binding	JJ	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
view	view	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
homology	homology	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
NF-P	NF-P	NN	I-NP	B-protein
motif	motif	NN	I-NP	I-protein
and	and	CC	O	O
other	other	JJ	B-NP	O
Ets	Ets	NN	I-NP	B-DNA
proto-oncoprotein-binding	proto-oncoprotein-binding	JJ	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
postulated	postulate	VBN	I-VP	O
that	that	IN	B-SBAR	O
NF-P1	NF-P1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NF-P2	NF-P2	NN	I-NP	B-protein
belong	belong	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ets	Ets	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
.	.	.	O	O

Results	Result	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
binding	bind	VBG	I-NP	O
competition	competition	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
nevertheless	nevertheless	RB	B-ADVP	O
,	,	,	O	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
NF-P1	NF-P1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NF-P2	NF-P2	NN	I-NP	B-protein
are	be	VBP	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
but	but	CC	O	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
Ets	Ets	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
e.g.	e.g.	FW	B-NP	O
,	,	,	O	O
Ets-1	Ets-1	NN	B-NP	B-protein
,	,	,	O	O
Ets-2	Ets-2	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
NF-AT/Elf-1	NF-AT/Elf-1	NN	B-NP	B-protein
,	,	,	O	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B1	B1	NN	I-NP	I-protein
(	(	(	O	O
p50/p105	p50/p105	NN	B-NP	O
)	)	)	O	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
T-lymphocytes	T-lymphocyte	NNS	I-NP	I-cell_type
via	via	IN	B-PP	O
CD2	CD2	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD28	CD28	NN	I-NP	B-protein
adhesion	adhesion	NN	I-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
.	.	.	O	O

Stimulation	Stimulation	NN	B-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
T-lymphocytes	T-lymphocyte	NNS	I-NP	I-cell_type
via	via	IN	B-PP	O
CD2	CD2	NN	B-NP	B-protein
and	and	CC	I-NP	O
CD28	CD28	NN	I-NP	B-protein
adhesion	adhesion	NN	I-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
induces	induce	VBZ	B-VP	O
a	a	DT	B-NP	O
long-lasting	long-lasting	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
(	(	(	O	O
>	>	SYM	B-NP	O
3	3	CD	B-NP	O
weeks	week	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
potent	potent	JJ	I-NP	O
activation	activation	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
accessory	accessory	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
but	but	CC	O	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
interleukin	interleukin	NN	I-NP	O
2	2	CD	I-NP	O
(	(	(	O	O
IL-2	IL-2	NN	B-NP	B-protein
)	)	)	O	O
secretion	secretion	NN	B-NP	O
and	and	CC	I-NP	O
receptivity	receptivity	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
and	and	CC	I-NP	O
prolonged	prolonged	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inducible	inducible	JJ	I-NP	B-DNA
CD25/IL-2	CD25/IL-2	NN	I-NP	I-DNA
receptor	receptor	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
(	(	(	O	I-DNA
IL-2R	IL-2R	NN	B-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
)	)	)	O	I-DNA
chain	chain	NN	B-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
participates	participate	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
IL-2	IL-2	NN	B-NP	B-protein
and	and	CC	O	O
IL-2R	IL-2R	NN	B-NP	B-DNA
alpha	alpha	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
multiple	multiple	JJ	B-NP	O
cellular	cellular	JJ	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
T-cell	T-cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
T-lymphocytes	T-lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
we	we	PRP	B-NP	O
previously	previously	RB	B-ADVP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B-related	B-related	JJ	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
CD2+CD28	CD2+CD28	NN	B-NP	B-protein
costimulation	costimulation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
long-term	long-term	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
p50/p65	p50/p65	NN	B-NP	B-protein
heterodimer	heterodimer	NN	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
p65/c-Rel	p65/c-Rel	NN	I-NP	B-protein
heterodimer	heterodimer	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
KBF1/p50	KBF1/p50	NN	B-NP	B-protein
homodimers	homodimer	NNS	I-NP	I-protein
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
p50	p50	NN	B-NP	B-protein
remains	remain	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
,	,	,	O	O
we	we	PRP	B-NP	O
focused	focus	VBD	B-VP	O
our	our	PRP$	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-DNA
B1	B1	NN	I-NP	I-DNA
(	(	(	O	I-DNA
p50/p105	p50/p105	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
regulation	regulation	NN	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
electrophoretic	electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
and	and	CC	O	O
Western	Western	JJ	B-NP	O
and	and	CC	I-NP	O
Northern	Northern	JJ	I-NP	O
blot	blot	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B1	B1	NN	I-NP	I-protein
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
T-cell	T-cell	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
via	via	IN	B-PP	O
CD2+CD28	CD2+CD28	NN	B-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
observed	observe	VBD	B-VP	O
a	a	DT	B-NP	O
transient	transient	JJ	I-NP	O
4-	4-	NN	I-NP	O
to	to	TO	B-PP	O
5-fold	5-fold	JJ	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B1	B1	NN	I-NP	I-protein
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
at	at	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
lasting	last	VBG	B-VP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
.	.	.	O	O

p50	p50	NN	B-NP	B-protein
DNA-binding	DNA-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
apparently	apparently	RB	B-ADVP	O
stays	stay	VBZ	B-VP	O
highly	highly	RB	I-VP	O
controlled	control	VBN	I-VP	O
when	when	WRB	B-ADVP	O
p105	p105	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
enhanced	enhance	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
stimulus	stimulus	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
T-cells	T-cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Partial	Partial	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
p50	p50	NN	B-NP	B-protein
and	and	CC	O	O
p105	p105	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B1	B1	NN	I-NP	I-protein
antisense	antisense	JJ	I-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
significantly	significantly	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
T-cell	T-cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
and	and	CC	O	O
CD25/IL-2R	CD25/IL-2R	NN	B-NP	O
alpha	alpha	NN	I-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-PP	O
250	250	CD	B-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O

Vitamin	Vitamin	NN	B-NP	B-protein
D	D	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
quantitation	quantitation	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
health	health	NN	B-NP	O
and	and	CC	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	B-protein
D	D	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
VDR	VDR	NN	B-NP	B-protein
)	)	)	O	O
concentration	concentration	NN	B-NP	O
was	be	VBD	B-VP	O
quantitated	quantitate	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
PBMC	PBMC	NN	B-NP	B-cell_type
)	)	)	O	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
absorptive	absorptive	JJ	B-NP	O
hypercalciuria	hypercalciuria	NN	I-NP	O
(	(	(	O	O
AH	AH	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
acquired	acquire	VBN	B-NP	O
or	or	CC	I-NP	O
transient	transient	JJ	I-NP	O
disease	disease	NN	I-NP	O
states	state	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

VDR	VDR	NN	B-NP	B-protein
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
resting	rest	VBG	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
not	not	RB	O	O
different	different	JJ	B-ADJP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
groups	group	NNS	I-NP	O
and	and	CC	O	O
represented	represent	VBN	B-NP	O
constitutive	constitutive	JJ	I-NP	O
receptor	receptor	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

Following	Follow	VBG	B-PP	O
activation	activation	NN	B-NP	O
with	with	IN	B-PP	O
phytohemagglutinin	phytohemagglutinin	NN	B-NP	B-protein
,	,	,	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
hypercalcitriolemia	hypercalcitriolemia	NN	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
greater	great	JJR	I-NP	O
VDR	VDR	NN	I-NP	B-protein
concentrations	concentration	NNS	I-NP	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
AH	AH	NN	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
value	value	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
6	6	CD	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
greater	great	JJR	I-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
VDR	VDR	NN	B-NP	B-protein
despite	despite	IN	B-PP	O
normal	normal	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Proliferation	Proliferation	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
assessed	assess	VBN	B-VP	O
from	from	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
thymidine	thymidine	NN	I-NP	O
incorporation	incorporation	NN	I-NP	O
was	be	VBD	B-VP	O
inversely	inversely	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
serum	serum	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
(	(	(	O	O
R	R	NN	B-NP	O
=	=	SYM	B-VP	O
-0.299	-0.299	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.048	0.048	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
PBMC	PBMC	NN	B-NP	B-cell_type
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
system	system	NN	I-NP	O
for	for	IN	B-PP	O
studying	study	VBG	B-VP	O
VDR	VDR	NN	B-NP	B-protein
status	status	NN	I-NP	O
in	in	IN	B-PP	O
transient	transient	JJ	B-NP	O
or	or	CC	I-NP	O
acquired	acquire	VBN	I-NP	O
states	state	NNS	I-NP	O
of	of	IN	B-PP	O
hypercalcitriolemia	hypercalcitriolemia	NN	B-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
studies	study	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
absorptive	absorptive	JJ	B-NP	O
hypercalciuria	hypercalciuria	NN	I-NP	O
disclosed	disclose	VBD	B-VP	O
it	it	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
heterogeneous	heterogeneous	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
vitamin	vitamin	NN	B-NP	O
D-dependent	D-dependent	JJ	I-NP	O
and	and	CC	I-NP	O
D-independent	D-independent	JJ	I-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
receptor	receptor	NN	B-NP	O
up-regulation	up-regulation	NN	I-NP	O
.	.	.	O	O

Reactive	Reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
intermediates	intermediate	NNS	I-NP	O
activate	activate	VBP	B-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
in	in	IN	B-PP	O
a	a	DT	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
kinase-dependent	kinase-dependent	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
vanadate	vanadate	NN	B-NP	O
activate	activate	VBP	B-VP	O
the	the	DT	B-NP	O
p56lck	p56lck	NN	I-NP	B-protein
and	and	CC	I-NP	O
p59fyn	p59fyn	NN	I-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
observed	observe	VBN	I-VP	O
that	that	IN	B-SBAR	O
ionizing	ionize	VBG	B-VP	O
radiation	radiation	NN	B-NP	O
induces	induce	VBZ	B-VP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
B-lymphocyte	B-lymphocyte	NN	I-NP	I-cell_type
precursors	precursor	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
unidentified	unidentified	JJ	B-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
and	and	CC	O	O
this	this	DT	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
is	be	VBZ	B-VP	O
substantially	substantially	RB	I-VP	O
augmented	augment	VBN	I-VP	O
by	by	IN	B-PP	O
vanadate	vanadate	NN	B-NP	O
.	.	.	O	O

Ionizing	Ionize	VBG	B-VP	O
radiation	radiation	NN	B-NP	O
generates	generate	VBZ	B-VP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
intermediates	intermediate	NNS	I-NP	O
(	(	(	O	O
ROI	ROI	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
H2O2	H2O2	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
ROI	ROI	NN	I-NP	O
generator	generator	NN	I-NP	O
that	that	WDT	B-NP	O
readily	readily	RB	B-ADVP	O
crosses	cross	VBZ	B-VP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
membrane	membrane	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
used	use	VBD	B-VP	O
H2O2	H2O2	NN	B-NP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
ROI	ROI	NN	B-NP	O
on	on	IN	B-PP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
now	now	RB	B-ADVP	O
provide	provide	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
tyrosine	tyrosine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
herbimycin	herbimycin	NN	I-NP	O
A	A	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
free	free	JJ	I-NP	O
radical	radical	NN	I-NP	O
scavenger	scavenger	NN	I-NP	O
N-acetyl-cysteine	N-acetyl-cysteine	NN	I-NP	O
inhibit	inhibit	VBP	B-VP	O
both	both	CC	O	O
radiation-induced	radiation-induced	JJ	B-NP	O
and	and	CC	I-NP	O
H2O2-induced	H2O2-induced	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
activation	activation	NN	B-NP	O
triggered	trigger	VBN	B-VP	O
by	by	IN	B-PP	O
ROI	ROI	NN	B-NP	O
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
.	.	.	O	O

H2O2	H2O2	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
stimulate	stimulate	VB	I-VP	O
Ins-1	Ins-1	NN	B-NP	B-protein
,	,	,	O	O
4	4	CD	B-NP	O
,	,	,	O	O
5-P3	5-P3	NN	B-NP	O
production	production	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
tyrosine	tyrosine	NN	I-NP	O
kinase-dependent	kinase-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
calcium	calcium	NN	B-NP	O
signals	signal	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
greatly	greatly	RB	I-VP	O
augmented	augment	VBN	I-VP	O
by	by	IN	B-PP	O
vanadate	vanadate	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
synergistic	synergistic	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
by	by	IN	B-PP	O
H2O2	H2O2	NN	B-NP	O
plus	plus	CC	I-NP	O
vanadate	vanadate	NN	I-NP	B-protein
included	include	VBD	B-VP	I-protein
physiologically	physiologically	RB	B-NP	I-protein
relevant	relevant	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
PLC	PLC	NN	B-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Although	Although	IN	B-SBAR	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
with	with	IN	B-PP	O
H2O2	H2O2	NN	B-NP	O
alone	alone	RB	B-ADVP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
src	src	NN	B-NP	B-protein
family	family	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
,	,	,	O	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
H2O2	H2O2	NN	B-NP	O
plus	plus	CC	I-NP	O
vanadate	vanadate	NN	I-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
p56lck	p56lck	NN	I-NP	B-protein
and	and	CC	I-NP	O
p59fyn	p59fyn	NN	I-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
combined	combined	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
phosphatases	phosphatas	NNS	B-NP	B-protein
and	and	CC	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
kinases	kinase	NNS	B-NP	B-protein
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
synergistic	synergistic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
H2O2	H2O2	NN	B-NP	O
plus	plus	CC	I-NP	O
vanadate	vanadate	NN	I-NP	O
.	.	.	O	O

Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
by	by	IN	B-PP	O
ROI	ROI	NN	B-NP	O
may	may	MD	B-VP	O
thus	thus	RB	I-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pleiotropic	pleiotropic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
ROI	ROI	NN	B-NP	O
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
including	include	VBG	B-PP	O
downstream	downstream	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
PLC	PLC	NN	B-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
and	and	CC	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein

Influence	Influence	NN	B-NP	O
of	of	IN	B-PP	O
sex	sex	NN	B-NP	B-protein
hormone	hormone	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
globulin	globulin	NN	I-NP	I-protein
and	and	CC	I-NP	O
serum	serum	NN	I-NP	B-protein
albumin	albumin	NN	I-NP	I-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
conversion	conversion	NN	I-NP	O
of	of	IN	B-PP	O
androstenedione	androstenedione	NN	B-NP	O
to	to	TO	B-PP	O
testosterone	testosterone	NN	B-NP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
erythrocytes	erythrocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
serum	serum	NN	I-NP	I-protein
albumin	albumin	NN	I-NP	I-protein
and	and	CC	O	O
sex	sex	NN	B-NP	B-protein
hormone	hormone	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
globulin	globulin	NN	I-NP	I-protein
(	(	(	O	O
SHBG	SHBG	NN	B-NP	B-protein
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
enzymic	enzymic	JJ	I-NP	O
conversion	conversion	NN	I-NP	O
of	of	IN	B-PP	O
androstenedione	androstenedione	NN	B-NP	O
to	to	TO	B-PP	O
testosterone	testosterone	NN	B-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
erythrocytes	erythrocyte	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
and	and	CC	I-NP	O
albumin	albumin	NN	I-NP	O
delayed	delay	VBD	B-VP	O
the	the	DT	B-NP	O
conversion	conversion	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
androstenedione	androstenedione	NN	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
SHBG	SHBG	NN	B-NP	B-protein
increased	increase	VBD	B-VP	O
it	it	PRP	B-NP	O
markedly	markedly	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
SHBG	SHBG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
largely	largely	RB	I-VP	O
abolished	abolish	VBN	I-VP	O
by	by	IN	B-PP	O
heating	heat	VBG	B-VP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
saturating	saturate	VBG	B-VP	O
its	its	PRP$	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
by	by	IN	B-PP	O
DHT	DHT	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
proteins	protein	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
binding	bind	VBG	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
albumin	albumin	NN	B-NP	B-protein
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
retarding	retard	VBG	B-VP	O
androstenedione	androstenedione	NN	B-NP	O
uptake	uptake	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
erythrocytes	erythrocyte	NNS	I-NP	B-cell_type
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
binding	binding	NN	I-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
SHBG	SHBG	NN	B-NP	B-protein
for	for	IN	B-PP	O
testosterone	testosterone	NN	B-NP	O
facilitates	facilitate	VBZ	B-VP	O
the	the	DT	B-NP	O
diffusion	diffusion	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
steroid	steroid	NN	I-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	O	O
,	,	,	O	O
displaces	displace	VBZ	B-VP	O
the	the	DT	B-NP	O
chemical	chemical	JJ	I-NP	O
equilibrium	equilibrium	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
.	.	.	O	O

Glucocorticoids	Glucocorticoid	NNS	B-NP	O
and	and	CC	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
.	.	.	O	O

I	I	PRP	B-NP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
antigen-stimulated	antigen-stimulated	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
a	a	DT	B-NP	O
2-	2-	CD	I-NP	O
to	to	TO	B-PP	O
3-fold	3-fold	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
noted	note	VBN	I-VP	O
after	after	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
mitogen	mitogen	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
extend	extend	VBP	B-VP	O
these	these	DT	B-NP	O
observations	observation	NNS	I-NP	O
to	to	TO	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
immunization	immunization	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
unilateral	unilateral	JJ	B-NP	O
immunization	immunization	NN	I-NP	O
of	of	IN	B-PP	O
adrenalectomized	adrenalectomize	VBN	B-NP	O
male	male	JJ	I-NP	O
rats	rat	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
sites	site	NNS	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
,	,	,	O	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
suspensions	suspension	NNS	I-NP	O
of	of	IN	B-PP	O
homolateral	homolateral	JJ	B-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
over	over	IN	B-PP	O
those	those	DT	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
contralateral	contralateral	JJ	I-NP	O
nonimmunized	nonimmunized	JJ	I-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
animal	animal	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
association	association	NN	I-NP	O
constant	constant	NN	I-NP	O
for	for	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
stereospecificity	stereospecificity	NN	I-NP	O
for	for	IN	B-PP	O
various	various	JJ	B-NP	O
steroids	steroid	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	O
and	and	CC	I-NP	O
nuclear	nuclear	JJ	I-NP	O
association	association	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cytoplasmic-to-nuclear	cytoplasmic-to-nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
a	a	DT	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
sites	site	NNS	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
homolateral	homolateral	JJ	I-NP	O
and	and	CC	I-NP	O
controlateral	controlateral	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
were	be	VBD	B-VP	O
equally	equally	RB	B-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
measurements	measurement	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
incorporation	incorporation	NN	I-NP	O
of	of	IN	B-PP	O
radiolabeled	radiolabele	VBN	B-NP	O
precursors	precursor	NNS	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
,	,	,	O	O
RNA	RNA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
measurements	measurement	NNS	B-NP	O
of	of	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
cell	cell	NN	I-NP	O
survival	survival	NN	I-NP	O
.	.	.	O	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	I-NP	O
actions	action	NNS	I-NP	O
in	in	IN	B-PP	O
rat	rat	NN	B-NP	B-cell_type
thymocytes	thymocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
immunologically	immunologically	RB	B-NP	O
stimulated	stimulate	VBN	I-NP	O
human	human	JJ	I-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

After	After	IN	B-PP	O
reviewing	review	VBG	B-VP	O
briefly	briefly	RB	B-ADVP	O
our	our	PRP$	B-NP	O
earlier	early	JJR	I-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
in	in	IN	B-PP	O
thymus	thymus	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
outlined	outline	VBN	I-VP	O
results	result	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
two	two	CD	I-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
current	current	JJ	B-NP	O
interest	interest	NN	I-NP	O
in	in	IN	B-PP	O
our	our	PRP$	B-NP	O
laboratories	laboratory	NNS	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
``	``	``	I-NP	O
life-cycle	life-cycle	NN	I-NP	O
''	''	''	O	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	I-NP	O
complexes	complex	NNS	I-NP	O
in	in	IN	B-PP	O
thymus	thymus	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
sensitivity	sensitivity	NN	B-NP	O
in	in	IN	B-PP	O
immunologically	immunologically	RB	B-NP	B-cell_type
stimulated	stimulate	VBN	I-NP	I-cell_type
human	human	JJ	I-NP	I-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Several	Several	JJ	B-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
results	result	NNS	I-NP	O
on	on	IN	B-PP	O
energetics	energetic	NNS	B-NP	O
and	and	CC	I-NP	O
kinetics	kinetic	NNS	I-NP	O
of	of	IN	B-PP	O
hormone	hormone	NN	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
rat	rat	NN	B-NP	B-cell_type
thymus	thymus	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
require	require	VB	I-VP	O
extension	extension	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
simplest	simple	JJS	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
hormone-receptor	hormone-receptor	NN	B-NP	O
transformations	transformation	NNS	I-NP	O
in	in	IN	B-PP	O
intact	intact	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

ATP-depletion	ATP-depletion	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
nonbinding	nonbinding	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
;	;	:	O	O
``	``	``	B-VP	O
chase	chase	VB	I-VP	O
''	''	''	O	O
experiments	experiment	NNS	B-NP	O
suggest	suggest	VBP	B-VP	O
reaction	reaction	NN	B-NP	O
of	of	IN	B-PP	O
hormone	hormone	NN	B-NP	O
directly	directly	RB	B-ADVP	O
with	with	IN	B-PP	O
nuclear-bound	nuclear-bound	JJ	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
;	;	:	O	O
experiments	experiment	NNS	B-NP	O
on	on	IN	B-PP	O
depletion	depletion	NN	B-NP	O
and	and	CC	I-NP	O
replenishment	replenishment	NN	I-NP	O
of	of	IN	B-PP	O
cytoplasmic	cytoplasmic	JJ	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
using	use	VBG	B-VP	O
cortisol	cortisol	NN	B-NP	O
and	and	CC	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
subpopulations	subpopulation	NNS	I-NP	O
of	of	IN	B-PP	O
nuclear-bound	nuclear-bound	JJ	B-NP	B-protein
hormone-receptor	hormone-receptor	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
mitogen	mitogen	NN	B-NP	O
or	or	CC	O	O
immunologic	immunologic	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
culture	culture	NN	B-NP	O
leads	lead	VBZ	B-VP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
or	or	CC	I-NP	O
so	so	RB	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
striking	striking	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
sites	site	NNS	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
believe	believe	VBP	B-VP	O
this	this	DT	B-NP	O
increase	increase	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
partial	partial	JJ	B-NP	O
synchronization	synchronization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
population	population	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
receptor	receptor	NN	B-NP	O
content	content	NN	I-NP	O
is	be	VBZ	B-VP	O
high	high	JJ	B-ADJP	O
.	.	.	O	O

Contrary	Contrary	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
widely	widely	RB	I-NP	O
held	held	JJ	I-NP	O
view	view	NN	I-NP	O
that	that	IN	B-SBAR	O
mitogen-stimulated	mitogen-stimulated	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
become	become	VBP	B-VP	O
insensitive	insensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
experiments	experiment	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
thymidine	thymidine	NN	B-NP	O
and	and	CC	I-NP	O
uridine	uridine	NN	I-NP	O
incorporation	incorporation	NN	I-NP	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	O
uptake	uptake	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
are	be	VBP	B-VP	O
highly	highly	RB	B-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
to	to	TO	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
at	at	IN	B-PP	O
24	24	CD	B-NP	O
,	,	,	I-NP	O
48	48	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
72	72	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
with	with	IN	B-PP	O
concanavalin	concanavalin	NN	B-NP	O
A	A	NN	I-NP	O
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
binding	binding	NN	I-NP	O
in	in	IN	B-PP	O
chronic	chronic	JJ	B-NP	B-cell_type
lymphatic	lymphatic	JJ	I-NP	I-cell_type
leukemia	leukemia	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

A	A	DT	B-NP	O
reliable	reliable	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O
for	for	IN	B-PP	O
isolating	isolate	VBG	B-VP	O
3H-triamcinolone	3H-triamcinolone	JJ	B-NP	B-protein
acetonide	acetonide	NN	I-NP	I-protein
(	(	(	O	I-protein
3H-TA	3H-TA	NN	B-NP	I-protein
)	)	)	O	I-protein
receptor	receptor	NN	B-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
from	from	IN	B-PP	O
purified	purify	VBN	B-NP	O
chronic	chronic	JJ	I-NP	O
lymphatic	lymphatic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
CLL	CLL	NN	B-NP	O
)	)	)	O	O
lymphocyte	lymphocyte	NN	B-NP	O
nuclei	nucleus	NNS	I-NP	O
,	,	,	O	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
carbobenzoxy-L-phenylalanine	carbobenzoxy-L-phenylalanine	NN	B-NP	O
(	(	(	O	O
CBZ-L-phe	CBZ-L-phe	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
breakdown	breakdown	NN	B-NP	O
of	of	IN	B-PP	O
hormone-receptor	hormone-receptor	NN	B-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
during	during	IN	B-PP	O
extraction	extraction	NN	B-NP	O
of	of	IN	B-PP	O
nuclei	nucleus	NNS	B-NP	O
with	with	IN	B-PP	O
0.6M	0.6M	NN	B-NP	O
KCl	KCl	NN	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
this	this	DT	B-NP	O
method	method	NN	I-NP	O
,	,	,	O	O
specific	specific	JJ	B-NP	O
nuclear	nuclear	JJ	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
binding	binding	NN	I-NP	O
was	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
in	in	IN	B-PP	O
14/14	14/14	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
untreated	untreated	JJ	B-NP	O
CLL	CLL	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
nuclear-associated	nuclear-associated	JJ	B-NP	B-protein
3H-TA	3H-TA	NN	I-NP	I-protein
and	and	CC	I-NP	O
peripheral	peripheral	JJ	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
or	or	CC	O	O
rosetting	rosette	VBG	B-VP	O
ability	ability	NN	B-NP	O
of	of	IN	B-PP	O
circulating	circulate	VBG	B-VP	B-cell_type
lymphocytes	lymphocyte	NNS	B-NP	I-cell_type
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
closely-linked	closely-linked	JJ	I-NP	O
NFAT/octamer	NFAT/octamer	NN	I-NP	O
and	and	CC	O	O
HMG	HMG	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
(	(	(	O	O
Y	Y	NN	B-NP	O
)	)	)	O	O
binding	binding	NN	B-NP	O
sites	site	NNS	I-NP	O
are	be	VBP	B-VP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
interleukin-4	interleukin-4	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
immediate	immediate	JJ	I-NP	B-DNA
upstream	upstream	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
(	(	(	O	O
from	from	IN	B-PP	O
position	position	NN	B-NP	B-DNA
-12	-12	CD	I-NP	I-DNA
to	to	TO	B-PP	I-DNA
-270	-270	CD	B-NP	I-DNA
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	B-DNA
interleukin	interleukin	NN	I-NP	I-DNA
4	4	CD	I-NP	I-DNA
(	(	(	O	I-DNA
Il-4	Il-4	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
harbors	harbor	VBZ	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
cell-type	cell-type	NN	I-NP	O
specific	specific	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphoma	lymphoma	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Il-4	Il-4	NN	I-NP	B-DNA
promoter/enhancer	promoter/enhancer	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
stimulated	stimulate	VBN	I-VP	O
by	by	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
esters	ester	NNS	I-NP	O
,	,	,	O	O
Ca++	Ca++	JJ	B-NP	O
ionophores	ionophore	NNS	I-NP	O
and	and	CC	O	O
agonists	agonist	NNS	B-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
and	and	CC	O	O
inhibited	inhibit	VBN	B-VP	O
by	by	IN	B-PP	O
low	low	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immunosuppressant	immunosuppressant	JJ	I-NP	O
cyclosporin	cyclosporin	NN	I-NP	O
A	A	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Il-4	Il-4	NN	I-NP	B-DNA
promoter/enhancer	promoter/enhancer	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
transcriptionally	transcriptionally	RB	B-ADJP	O
inactive	inactive	JJ	I-ADJP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphoma	lymphoma	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

DNase	DNase	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
footprint	footprint	NN	I-NP	O
protection	protection	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
six	six	CD	B-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Il-4	Il-4	NN	I-NP	B-DNA
promoter/enhancer	promoter/enhancer	NN	I-NP	I-DNA
to	to	TO	B-VP	O
be	be	VB	I-VP	O
bound	bind	VBN	I-VP	O
by	by	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
from	from	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Among	Among	IN	B-PP	O
them	them	PRP	B-NP	O
are	be	VBP	B-VP	O
four	four	CD	B-NP	O
purine	purine	JJ	I-NP	B-DNA
boxes	box	NNS	I-NP	I-DNA
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
described	describe	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
motifs	motif	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Il-2	Il-2	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

They	They	PRP	B-NP	O
contain	contain	VBP	B-VP	O
the	the	DT	B-NP	O
motif	motif	NN	I-NP	O
GGAAA	GGAAA	NN	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
recognized	recognize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
inducible	inducible	JJ	I-NP	O
and	and	CC	I-NP	O
cyclosporin	cyclosporin	NN	I-NP	O
A-sensitive	A-sensitive	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
NFAT-1	NFAT-1	NN	I-NP	B-protein
.	.	.	O	O

Three	Three	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Il-4	Il-4	NN	I-NP	B-DNA
NFAT-1	NFAT-1	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
closely	closely	RB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
weak	weak	JJ	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
Octamer	Octamer	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

Several	Several	JJ	B-NP	O
purine	purine	NN	I-NP	B-DNA
boxes	box	NNS	I-NP	I-DNA
and	and	CC	O	O
an	an	DT	B-NP	O
AT-rich	AT-rich	JJ	I-NP	B-DNA
protein-binding	protein-binding	JJ	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Il-4	Il-4	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
are	be	VBP	B-VP	O
also	also	RB	I-VP	O
recognized	recognize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	B-protein
mobility	mobility	NN	I-NP	I-protein
group	group	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
HMG	HMG	NN	I-NP	B-protein
I	I	CD	I-NP	I-protein
(	(	(	O	I-protein
Y	Y	NN	B-NP	I-protein
)	)	)	O	I-protein
.	.	.	O	O

Whereas	Whereas	IN	B-SBAR	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
NFAT-1	NFAT-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
Octamer	Octamer	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
enhance	enhance	VBP	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Il-4	Il-4	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
HMG	HMG	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
(	(	(	O	I-protein
Y	Y	NN	B-NP	I-protein
)	)	)	O	I-protein
suppresses	suppress	VBZ	B-VP	O
its	its	PRP$	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
Il-4	Il-4	NN	B-NP	B-protein
transcription	transcription	NN	I-NP	O
in	in	IN	B-PP	O
resting	rest	VBG	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Reversibility	Reversibility	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
differentiated	differentiate	VBN	I-NP	O
state	state	NN	I-NP	O
in	in	IN	B-PP	O
somatic	somatic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
de	de	FW	B-NP	O
novo	novo	FW	I-NP	O
gene	gene	NN	I-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
multinucleated	multinucleated	JJ	B-NP	B-cell_line
heterokaryons	heterokaryon	NNS	I-NP	I-cell_line
has	have	VBZ	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
differentiated	differentiate	VBN	I-NP	O
state	state	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
irreversible	irreversible	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
reprogrammed	reprogramme	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
combinations	combination	NNS	I-NP	O
of	of	IN	B-PP	O
trans-acting	trans-acting	JJ	B-NP	B-protein
regulatory	regulatory	JJ	I-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
properties	property	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
exploited	exploit	VBN	I-VP	O
to	to	TO	I-VP	O
design	design	VB	I-VP	O
strategies	strategy	NNS	B-NP	O
for	for	IN	B-PP	O
identifying	identify	VBG	B-VP	O
novel	novel	JJ	B-NP	O
regulators	regulator	NNS	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O

Phosphatidylcholine	Phosphatidylcholine	NN	B-NP	O
hydrolysis	hydrolysis	NN	I-NP	O
activates	activate	VBZ	B-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
increases	increase	VBZ	B-VP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
replication	replication	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
monocytes	monocyte	NNS	B-NP	I-cell_type
and	and	CC	O	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	B-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
tested	test	VBN	I-VP	O
whether	whether	IN	B-SBAR	O
breakdown	breakdown	NN	B-NP	O
of	of	IN	B-PP	O
phosphatidylcholine	phosphatidylcholine	NN	B-NP	O
(	(	(	O	O
PC	PC	NN	B-NP	O
)	)	)	O	O
initiated	initiate	VBN	B-VP	O
by	by	IN	B-PP	O
exogenous	exogenous	JJ	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
PC-specific	PC-specific	JJ	I-NP	B-cell_line
phospholipase	phospholipase	NN	I-NP	I-cell_line
C	C	NN	I-NP	I-cell_line
(	(	(	O	O
PC-PLC	PC-PLC	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
Bacillus	Bacillus	NN	B-NP	O
cereus	cereus	NN	I-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
overexpression	overexpression	NN	I-NP	O
of	of	IN	B-PP	O
PC-PLC	PC-PLC	NN	B-NP	B-protein
induces	induce	VBZ	B-VP	O
functional	functional	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
increases	increase	VBZ	B-VP	O
human	human	JJ	B-NP	B-DNA
immunodeficiency	immunodeficiency	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
(	(	(	O	I-DNA
HIV	HIV	NN	B-NP	I-DNA
)	)	)	O	I-DNA
enhancer	enhancer	NN	B-NP	I-DNA
activity	activity	NN	I-NP	O
.	.	.	O	O

PC-PLC-activated	PC-PLC-activated	JJ	B-NP	O
hydrolysis	hydrolysis	NN	I-NP	O
of	of	IN	B-PP	O
PC	PC	NN	B-NP	B-cell_type
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
bona	bona	NN	B-NP	O
fide	fide	NN	I-NP	O
p50/p65	p50/p65	NN	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
different	different	JJ	I-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
or	or	CC	I-NP	O
murine	murine	JJ	I-NP	O
origin	origin	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
turnover	turnover	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
phospholipids	phospholipid	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
PC-PLC-treated	PC-PLC-treated	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
by	by	IN	B-PP	O
PC-PLC	PC-PLC	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
depend	depend	VB	I-VP	O
on	on	IN	B-PP	O
de	de	FW	B-NP	O
novo	novo	FW	I-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
or	or	CC	O	O
autocrine	autocrine	JJ	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
or	or	CC	O	O
interleukin	interleukin	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
human	human	JJ	B-NP	O
monocytic	monocytic	JJ	I-NP	O
and	and	CC	I-NP	O
lymphoblastoid	lymphoblastoid	JJ	I-NP	B-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
by	by	IN	B-PP	O
PC-PLC	PC-PLC	NN	B-NP	B-protein
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
clear	clear	JJ	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
luciferase	luciferase	NN	B-NP	B-DNA
expression	expression	NN	I-NP	I-DNA
vectors	vector	NNS	I-NP	I-DNA
placed	place	VBN	B-VP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
synthetic	synthetic	JJ	B-NP	B-DNA
kappa	kappa	NN	I-NP	I-DNA
B	B	NN	I-NP	I-DNA
enhancers	enhancer	NNS	I-NP	I-DNA
or	or	CC	O	O
wild	wild	JJ	B-NP	O
type	type	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
kappa	kappa	NN	B-NP	O
B-mutated	B-mutated	JJ	B-ADJP	O
,	,	,	O	O
HIV	HIV	NN	B-NP	B-DNA
long	long	JJ	I-NP	I-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
constructs	construct	NNS	I-NP	I-DNA
.	.	.	O	O

HIV	HIV	NN	B-NP	O
replication	replication	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
by	by	IN	B-PP	O
PC-PLC	PC-PLC	NN	B-NP	B-protein
in	in	IN	B-PP	O
chronically	chronically	RB	B-NP	O
infected	infected	JJ	I-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
and	and	CC	O	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	B-NP	I-cell_type
.	.	.	O	O

NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
promoted	promote	VBN	B-VP	O
by	by	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
exogenous	exogenous	JJ	B-NP	O
PC-PLC	PC-PLC	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
intense	intense	JJ	I-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
diacylglycerol	diacylglycerol	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
phosphatidylinositol-specific	phosphatidylinositol-specific	JJ	I-NP	O
PLC	PLC	NN	I-NP	O
from	from	IN	B-PP	O
B.cereus	B.cereus	NNP	B-NP	O
also	also	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
diacylglycerol	diacylglycerol	NN	B-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
activate	activate	VB	I-VP	O
kappa	kappa	NN	B-NP	O
B	B	NN	I-NP	O
enhancer-directed	enhancer-directed	JJ	I-NP	O
vectors	vector	NNS	I-NP	O
.	.	.	O	O

PC-PLC-induced	PC-PLC-induced	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
activation	activation	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
phorbol	phorbol	NN	B-NP	B-protein
ester-inducible	ester-inducible	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
C	C	NN	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
transduction	transduction	NN	I-NP	O
pathway	pathway	NN	I-NP	O
,	,	,	O	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
specific	specific	JJ	B-NP	O
PC	PC	NN	I-NP	O
breakdown	breakdown	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
functional	functional	JJ	B-ADJP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
monocytes	monocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
by	by	IN	B-PP	O
various	various	JJ	B-NP	O
transmembrane	transmembrane	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
HIV	HIV	NN	B-NP	O
transcription	transcription	NN	I-NP	O
through	through	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	O
B-dependent	B-dependent	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIV	HIV	NN	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

Novel	Novel	JJ	B-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
.	.	.	O	O

Glucocorticoids	Glucocorticoid	NNS	B-NP	O
inhibit	inhibit	VBP	B-VP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
through	through	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Interaction	Interaction	NN	B-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
with	with	IN	B-PP	O
its	its	PRP$	B-NP	O
high	high	JJ	I-NP	B-protein
affinity	affinity	NN	I-NP	I-protein
membrane	membrane	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
(	(	(	O	O
IL-2R	IL-2R	NN	B-NP	B-protein
)	)	)	O	O
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
induces	induce	VBZ	B-VP	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
and	and	CC	O	O
mediates	mediate	VBZ	B-VP	O
effector	effector	NN	B-NP	O
functions	function	NNS	I-NP	O
.	.	.	O	O

Glucocorticoids	Glucocorticoid	NNS	B-NP	O
inhibit	inhibit	VBP	B-VP	O
IL-2	IL-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
TCR-mediated	TCR-mediated	JJ	B-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
asked	ask	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
they	they	PRP	B-NP	O
also	also	RB	B-ADVP	O
inhibit	inhibit	VBP	B-VP	O
the	the	DT	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
through	through	IN	B-PP	O
IL-2R	IL-2R	NN	B-NP	B-protein
.	.	.	O	O

Human	Human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
stimulated	stimulate	VBN	B-VP	O
with	with	IN	B-PP	O
PMA	PMA	NN	B-NP	O
for	for	IN	B-PP	O
48	48	CD	B-NP	O
h	h	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	B-cell_type
blasts	blast	NNS	I-NP	I-cell_type
)	)	)	O	O
,	,	,	O	O
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
with	with	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
incremental	incremental	JJ	B-NP	O
dosages	dosage	NNS	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
(	(	(	O	O
Dex	Dex	NN	B-NP	O
;	;	:	O	O
10	10	CD	B-NP	O
(	(	(	O	O
-5	-5	CD	B-NP	O
)	)	)	O	O
-10	-10	CD	B-NP	O
(	(	(	O	O
-9	-9	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Dex	Dex	NN	B-NP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
IL-2-dependent	IL-2-dependent	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
PMA	PMA	NN	B-NP	B-cell_type
blasts	blast	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
(	(	(	O	O
IC50	IC50	NN	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
x	x	NN	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
-8	-8	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Cell	Cell	NN	B-NP	O
surface	surface	NN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
IL-2R	IL-2R	NN	B-NP	B-protein
alpha-	alpha-	NN	I-NP	I-protein
and	and	CC	O	O
beta-chains	beta-chain	NNS	B-NP	B-protein
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
immunofluorescence	immunofluorescence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
Dex	Dex	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
Scatchard	Scatchard	NN	B-NP	O
plot	plot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
125I-labeled	125I-labeled	JJ	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
Dex	Dex	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
,	,	,	O	O
thus	thus	RB	B-ADVP	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
inhibition	inhibition	NN	B-NP	O
is	be	VBZ	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
postreceptor	postreceptor	NN	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
proliferation	proliferation	NN	I-NP	O
by	by	IN	B-PP	O
Dex	Dex	NN	B-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
IL-2-dependent	IL-2-dependent	JJ	I-NP	O
tyrosine	tyrosine	NN	I-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
intracellular	intracellular	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
retinoblastoma	retinoblastoma	NN	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
Rb	Rb	NN	I-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
controlling	control	VBG	B-VP	O
the	the	DT	B-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O

IL-2-dependent	IL-2-dependent	JJ	B-NP	O
IL-2R	IL-2R	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
PMA	PMA	NN	B-NP	B-cell_type
blasts	blast	NNS	I-NP	I-cell_type
and	and	CC	O	O
NF-kB	NF-kB	NN	B-NP	B-protein
induction	induction	NN	I-NP	O
in	in	IN	B-PP	O
resting	rest	VBG	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
Dex	Dex	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
glucocorticoids	glucocorticoid	NNS	B-NP	O
inhibit	inhibit	VBP	B-VP	O
preactivated	preactivated	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
down-regulating	down-regulate	VBG	B-VP	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
through	through	IN	B-PP	O
IL-2R	IL-2R	NN	B-NP	B-protein
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
human	human	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
infection	infection	NN	I-NP	O
stimulates	stimulate	VBZ	B-VP	O
distinct	distinct	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B/rel	B/rel	NN	I-NP	I-protein
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
activities	activity	NNS	I-NP	O
in	in	IN	B-PP	O
myelomonoblastic	myelomonoblastic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HIV-1	HIV-1	NN	B-NP	O
)	)	)	O	O
infection	infection	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
myeloid	myeloid	JJ	I-NP	O
cell	cell	NN	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
infection	infection	NN	I-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
PLB-985	PLB-985	NN	I-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
PLB-985	PLB-985	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
monocyte-specific	monocyte-specific	JJ	I-NP	B-protein
surface	surface	NN	I-NP	I-protein
marker	marker	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
c-fms	c-fms	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
morphological	morphological	JJ	B-NP	O
alterations	alteration	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
differentiation	differentiation	NN	B-NP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
monocytic	monocytic	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

PLB-IIIB	PLB-IIIB	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
displayed	display	VBD	B-VP	O
a	a	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	O
B-like	B-like	JJ	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
or	or	CC	O	O
phorbol	phorbol	NN	B-NP	O
12-myristate	12-myristate	NN	I-NP	O
13-acetate	13-acetate	NN	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
parental	parental	JJ	I-NP	B-cell_line
PLB-985	PLB-985	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

This	This	DT	B-NP	O
unique	unique	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
,	,	,	I-NP	O
90	90	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
100	100	CD	B-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
binding	binding	NN	B-NP	O
specificity	specificity	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
within	within	IN	B-PP	O
the	the	DT	B-NP	O
PRDII	PRDII	NN	I-NP	B-DNA
domain	domain	NN	I-NP	I-DNA
of	of	IN	B-PP	O
beta	beta	SYM	B-NP	B-protein
interferon	interferon	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
characterize	characterize	VBP	B-VP	O
the	the	DT	B-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
proteins	protein	NNS	I-NP	O
and	and	CC	O	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
proteins	protein	NNS	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
induced	induce	VBN	I-VP	O
following	follow	VBG	B-PP	O
Sendai	Sendai	NNP	B-NP	O
paramyxovirus	paramyxovirus	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
70-kDa	70-kDa	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
RelA	RelA	NN	I-NP	I-protein
(	(	(	O	I-protein
p65	p65	NN	B-NP	I-protein
)	)	)	O	I-protein
subunit	subunit	NN	B-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
paramyxovirus	paramyxovirus	NN	I-NP	O
infection	infection	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
HIV-1	HIV-1	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Virus	Virus	NN	B-NP	O
infection	infection	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
alter	alter	VB	I-VP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
RelA	RelA	NN	B-NP	B-protein
(	(	(	O	O
p65	p65	NN	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
NFKB1	NFKB1	NN	B-NP	B-protein
(	(	(	O	O
p50	p50	NN	B-NP	B-protein
)	)	)	O	O
but	but	CC	O	O
rather	rather	RB	B-VP	O
affects	affect	VBZ	I-VP	O
the	the	DT	B-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
to	to	TO	B-VP	O
sequester	sequester	VB	I-VP	O
RelA	RelA	NN	B-NP	B-protein
(	(	(	O	O
p65	p65	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
constitutive	constitutive	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
RelA	RelA	NN	B-NP	B-protein
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-DNA
B-dependent	B-dependent	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
virally	virally	RB	I-NP	O
induced	induce	VBN	I-NP	O
90-	90-	CD	I-NP	O
to	to	TO	B-PP	O
100-kDa	100-kDa	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
binding	binding	NN	I-NP	O
specificity	specificity	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
PRDII	PRDII	NN	I-NP	B-DNA
domain	domain	NN	I-NP	I-DNA
and	and	CC	O	O
an	an	DT	B-NP	O
AT-rich	AT-rich	JJ	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
but	but	CC	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
cross-react	cross-react	VB	I-VP	O
with	with	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
subunit-specific	subunit-specific	JJ	I-NP	O
antisera	antiserum	NNS	I-NP	O
directed	direct	VBN	B-VP	O
against	against	IN	B-PP	O
NFKB1	NFKB1	NN	B-NP	B-protein
(	(	(	O	O
p105	p105	NN	B-NP	B-protein
or	or	CC	O	O
p50	p50	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
NFKB2	NFKB2	NN	B-NP	B-protein
(	(	(	O	O
p100	p100	NN	B-NP	B-protein
or	or	CC	O	O
p52	p52	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
RelA	RelA	NN	B-NP	B-protein
(	(	(	O	O
p65	p65	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
or	or	CC	O	O
c-rel	c-rel	NN	B-NP	B-protein
.	.	.	O	O

DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
90-	90-	CD	I-NP	O
to	to	TO	B-PP	O
100-kDa	100-kDa	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	B-protein
I	I	NN	I-NP	I-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
alpha/MAD-3	alpha/MAD-3	NN	I-NP	I-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
tryptic	tryptic	JJ	B-NP	O
digestion	digestion	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
proteins	protein	NNS	I-NP	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
related	relate	VBN	B-VP	O
.	.	.	O	O

Transient	Transient	JJ	B-NP	O
cotransfection	cotransfection	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
RelA	RelA	NN	B-NP	B-protein
and	and	CC	I-NP	O
NFKB1	NFKB1	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
maximally	maximally	RB	B-ADVP	O
stimulated	stimulate	VBD	B-VP	O
HIV-1	HIV-1	NN	B-NP	B-DNA
LTR-	LTR-	NN	I-NP	I-DNA
and	and	CC	O	O
NF-kappa	NF-kappa	NN	B-NP	O
B-dependent	B-dependent	JJ	I-NP	O
reporter	reporter	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
;	;	:	O	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	O
B-like	B-like	JJ	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
reflected	reflect	VBN	I-VP	O
in	in	IN	B-PP	O
higher	high	JJR	B-NP	O
constitutive	constitutive	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-DNA
B-regulated	B-regulated	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
HIV-1-infected	HIV-1-infected	JJ	B-NP	B-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Presence	Presence	NN	B-NP	O
of	of	IN	B-PP	O
estrogen-binding	estrogen-binding	JJ	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
on	on	IN	B-PP	O
macrophage-like	macrophage-like	JJ	B-NP	B-cell_type
synoviocytes	synoviocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
CD8+	CD8+	JJ	B-NP	O
,	,	,	I-NP	O
CD29+	CD29+	JJ	I-NP	O
,	,	,	I-NP	O
CD45RO+	CD45RO+	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
and	and	CC	I-NP	O
rheumatoid	rheumatoid	JJ	I-NP	O
synovium	synovium	NN	I-NP	O
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
estrogen-binding	estrogen-binding	JJ	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
(	(	(	O	O
EBS	EBS	NN	B-NP	B-DNA
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
synovial	synovial	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
of	of	IN	B-PP	O
male	male	JJ	B-NP	O
and	and	CC	I-NP	O
female	female	JJ	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
(	(	(	O	O
RA	RA	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
age-	age-	NN	B-NP	O
and	and	CC	O	O
sex-matched	sex-matched	JJ	B-NP	O
healthy	healthy	JJ	I-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

METHODS	METHODS	NNS	B-NP	O
.	.	.	O	O

Both	Both	CC	O	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
binding	binding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
(	(	(	O	O
reduced	reduce	VBN	B-VP	O
affinity	affinity	NN	B-NP	O
,	,	,	O	O
higher	high	JJR	B-NP	O
binding	binding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
)	)	)	O	O
EBS	EBS	NN	B-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
soluble	soluble	JJ	I-NP	O
and	and	CC	I-NP	O
nuclear	nuclear	JJ	I-NP	O
fractions	fraction	NNS	I-NP	O
of	of	IN	B-PP	O
homogenized	homogenize	VBN	B-NP	O
synovial	synovial	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
samples	sample	NNS	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
dextran-coated	dextran-coated	JJ	I-NP	O
charcoal	charcoal	NN	I-NP	O
method	method	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
what	what	WP	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
synovial	synovial	JJ	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
EBS	EBS	NN	B-NP	B-protein
,	,	,	O	O
cryosections	cryosection	NNS	B-NP	O
of	of	IN	B-PP	O
synovial	synovial	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
were	be	VBD	B-VP	O
immunostained	immunostaine	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
anti-estrogen	anti-estrogen	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
(	(	(	O	O
anti-ER	anti-ER	JJ	B-NP	B-protein
MAb	MAb	NN	I-NP	I-protein
)	)	)	O	O
using	use	VBG	B-VP	O
both	both	CC	O	O
immunofluorescence	immunofluorescence	NN	B-NP	O
and	and	CC	I-NP	O
immunoperoxidase	immunoperoxidase	NN	I-NP	O
techniques	technique	NNS	I-NP	O
.	.	.	O	O

Double	Double	JJ	B-NP	O
immunostaining	immunostaining	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
anti-ER	anti-ER	JJ	I-NP	B-protein
MAb	MAb	NN	I-NP	I-protein
and	and	CC	B-PP	O
with	with	IN	B-PP	O
specific	specific	JJ	B-NP	O
MAb	MAb	NN	I-NP	B-protein
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
different	different	JJ	B-NP	O
macrophage	macrophage	NN	I-NP	B-protein
antigens	antigen	NNS	I-NP	I-protein
(	(	(	O	O
Ber-MAC3	Ber-MAC3	NN	B-NP	O
,	,	,	O	O
MAC387	MAC387	NN	B-NP	B-protein
,	,	,	O	O
CD68	CD68	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
CD8+	CD8+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
subsets	subset	NNS	I-NP	I-cell_type
(	(	(	O	O
CD29+	CD29+	NN	B-NP	O
,	,	,	I-NP	O
CD45RO+	CD45RO+	NN	I-NP	O
and	and	CC	I-NP	O
CD29-	CD29-	NN	I-NP	B-protein
,	,	,	O	O
CD45RO-	CD45RO-	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
.	.	.	O	O

Higher	High	JJR	B-NP	O
affinity	affinity	NN	I-NP	O
EBS	EBS	NN	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
mostly	mostly	RB	B-ADVP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
cell	cell	NN	I-NP	O
fractions	fraction	NNS	I-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
RA	RA	NN	B-NP	B-protein
or	or	CC	O	O
control	control	NN	B-NP	O
synovial	synovial	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
(	(	(	O	O
28	28	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
33	33	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

These	These	DT	B-NP	O
EBS	EBS	NNP	I-NP	B-DNA
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O
in	in	IN	B-PP	O
soluble	soluble	JJ	B-NP	O
cell	cell	NN	I-NP	O
fractions	fraction	NNS	I-NP	O
(	(	(	O	O
11	11	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
33	33	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Immunostaining	Immunostaining	NN	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
estrogen	estrogen	NN	I-NP	B-cell_line
receptor-positive	receptor-positive	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
to	to	TO	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
macrophage-like	macrophage-like	JJ	I-NP	B-cell_type
synoviocytes	synoviocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
the	the	DT	B-NP	O
CD8+	CD8+	JJ	I-NP	O
,	,	,	I-NP	O
CD29+	CD29+	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
both	both	CC	B-PP	O
in	in	IN	B-PP	O
RA	RA	NN	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
control	control	NN	B-NP	O
synovial	synovial	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

Higher	High	JJR	B-NP	O
nuclear	nuclear	JJ	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
EBS	EBS	NN	B-NP	B-protein
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
more	more	RBR	B-NP	O
intense	intense	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
staining	staining	NN	I-NP	O
of	of	IN	B-PP	O
synoviocytes	synoviocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
.	.	.	O	O

CONCLUSION	CONCLUSION	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
conceivable	conceivable	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
immunomodulatory	immunomodulatory	JJ	I-NP	O
activity	activity	NN	I-NP	O
exerted	exert	VBN	B-VP	O
by	by	IN	B-PP	O
estrogens	estrogen	NNS	B-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
partly	partly	RB	B-VP	O
mediated	mediate	VBN	I-VP	O
through	through	IN	B-PP	O
their	their	PRP$	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
EBS	EBS	NN	B-NP	B-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
macrophage-like	macrophage-like	JJ	B-NP	B-cell_type
synoviocytes	synoviocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
functioning	function	VBG	B-VP	O
as	as	IN	B-PP	O
antigen-processing	antigen-processing	JJ	B-NP	O
and	and	CC	I-NP	O
antigen-presenting	antigen-presenting	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	B-PP	O
and	and	CC	I-PP	O
on	on	IN	B-PP	O
antigen-experienced	antigen-experienced	JJ	B-NP	B-cell_type
(	(	(	I-NP	I-cell_type
memory	memory	NN	I-NP	I-cell_type
)	)	)	I-NP	I-cell_type
CD8+	CD8+	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
(	(	(	O	O
CD29+	CD29+	JJ	B-ADJP	O
,	,	,	O	O
CD45RO+	CD45RO+	JJ	B-ADJP	O

